<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7793902</article-id><article-id pub-id-type="pmcid-ver">PMC7793902.1</article-id><article-id pub-id-type="pmcaid">7793902</article-id><article-id pub-id-type="pmcaiid">7793902</article-id><article-id pub-id-type="pmid">33424827</article-id><article-id pub-id-type="doi">10.3389/fimmu.2020.534501</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Insights Into Mucosal Innate Immune Responses in House Dust Mite-Mediated Allergic Asthma</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Abu Khweek</surname><given-names initials="A">Arwa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/20371/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="E">Eunsoo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/939408/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Joldrichsen</surname><given-names initials="MR">Marisa R.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/960510/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Amer</surname><given-names initials="AO">Amal O.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/15591/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Boyaka</surname><given-names initials="PN">Prosper N.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/56072/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Biology and Biochemistry, Birzeit University</institution>, <addr-line>Birzeit</addr-line>, <country>Palestine</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Microbial Infection and Immunity, The Ohio State University</institution>, <addr-line>Columbus, OH</addr-line>, <country>United States</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Veterinary Biosciences, The Ohio State University</institution>, <addr-line>Columbus, OH</addr-line>, <country>United States</country></aff><aff id="aff4"><sup>4</sup><institution>The Infectious Diseases Institute, The Ohio State University</institution>, <addr-line>Columbus, OH</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Eric Cox, Ghent University, Belgium</p></fn><fn fn-type="edited-by"><p>Reviewed by: Wayne Robert Thomas, University of Western Australia, Australia; Stewart J. Levine, National Heart, Lung, and Blood Institute (NHLBI), United States</p></fn><corresp id="c001">*Correspondence: Prosper N. Boyaka <email>boyaka.1@osu.edu</email></corresp><corresp id="c002">Amal O. Amer <email>amal.amer@osumc.edu</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Mucosal Immunity, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><issue-id pub-id-type="pmc-issue-id">351098</issue-id><elocation-id>534501</elocation-id><history><date date-type="received"><day>12</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>01</day><month>9</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>09</day><month>01</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2021-01-11 17:16:23.240"><day>11</day><month>01</month><year>2021</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2020 Abu Khweek, Kim, Joldrichsen, Amer and Boyaka.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Abu Khweek, Kim, Joldrichsen, Amer and Boyaka</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-11-534501.pdf"/><abstract><p>The prevalence of asthma has been rising steadily for several decades, and continues to be a major public health and global economic burden due to both direct and indirect costs. Asthma is defined as chronic heterogeneous inflammatory diseases characterized by airway obstruction, mucus production and bronchospasm. Different endotypes of asthma are being recognized based on the distinct pathophysiology, genetic predisposition, age, prognosis, and response to remedies. Mucosal innate response to environmental triggers such as pollen, cigarette smoke, fragrances, viral infection, and house dust mite (HDM) are now recognized to play an important role in allergic asthma. HDM are the most pervasive allergens that co-habitat with us, as they are ubiquitous in-house dusts, mattress and bedsheets, and feed on a diet of exfoliated human skin flakes. <italic toggle="yes">Dermatophagoides pteronyssinus</italic>, is one among several HDM identified up to date. During the last decade, extensive studies have been fundamental in elucidating the interactions between HDM allergens, the host immune systems and airways. Moreover, the paradigm in the field of HDM-mediated allergy has been shifted away from being solely a Th2-geared to a complex response orchestrated via extensive crosstalk between the epithelium, professional antigen presenting cells (APCs) and components of the adaptive immunity. In fact, HDM have several lessons to teach us about their allergenicity, the complex interactions that stimulate innate immunity in initiating and perpetuating the lung inflammation. Herein, we review main allergens of <italic toggle="yes">Dermatophagoides pteronyssinus</italic> and their interactions with immunological sentinels that promote allergic sensitization and activation of innate immunity, which is critical for the development of the Th2 biased adaptive immunity to HDM allergens and development of allergic asthma.</p></abstract><kwd-group><kwd>mucosal</kwd><kwd>innate immunity</kwd><kwd>asthma</kwd><kwd>house dust mite</kwd><kwd>allergy</kwd></kwd-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="166"/><page-count count="14"/><word-count count="13422"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Asthma is a chronic lung disease characterized by airway obstruction, mucus production and bronchospasm that affects approximately 339 million people worldwide (<xref rid="B1" ref-type="bibr">1</xref>). It is a cause of both premature death and reduced quality of life in individuals of all ages in all parts of the world. Not only the prevalence of asthma is increasing, but it continues to be a major public health and global economic burden due to both direct and indirect costs (<xref rid="B2" ref-type="bibr">2</xref>). The definition of asthma has evolved over the last three decades as our understanding of the pathophysiology and different clinical presentation has developed. During the twentieth century, researchers recognized constriction of airway smooth muscles and excessive sensitivity of the airway to external stimuli (hyper-responsiveness) as the key features of asthma. In the 1980s, it was established that airway inflammation was an essential feature, with structural changes in the airways (remodeling) present early in the development of the disease. Currently, it is well-accepted that asthma is a heterogeneous inflammatory disease associated with airways narrowing, swelling and excessive mucus production. It is also defined by the history of respiratory symptoms such as intermittent attacks of breathlessness, bronchoconstriction, coughing, wheezing, dyspnea, and airway inflammation (<xref rid="B3" ref-type="bibr">3</xref>&#8211;<xref rid="B5" ref-type="bibr">5</xref>).</p></sec><sec id="s2"><title>House Dust Mite Allergens and Their Roles in Asthma</title><p>House dust mites are small yet, extremely complex organisms that belong to the group of arthropods and thrive in humid indoor environment. They come in contact with humans mainly through mattresses and bedsheets, and live on a diet of skin scales and bio-debris accumulated in house dust. Hypersensitivity to HDM such as <italic toggle="yes">Dermatophagoides pteronyssinus</italic> aeroallergens contribute to atopic sensitization in 50&#8211;85% of asthmatics, and are strong inducers of allergenicity worldwide (<xref rid="B6" ref-type="bibr">6</xref>&#8211;<xref rid="B8" ref-type="bibr">8</xref>). In addition to genetic predisposition, mite sensitization, and exposure are important determinants of the subsequent development of asthma (<xref rid="B3" ref-type="bibr">3</xref>&#8211;<xref rid="B5" ref-type="bibr">5</xref>). Thus, patients with asthma and dust mite sensitivity show worsened bronchospasm and bronchial hyper-reactivity following exposure to mite allergen, while reduced symptoms are noted in a mite-free environment (<xref rid="B3" ref-type="bibr">3</xref>). The link between HDM and asthma is further supported by the fact that the levels of HDM exposure and sensitization are strong predictors for asthma in clinics (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). Furthermore, the synergy between mite sensitization, exposure and respiratory viral infection enhances the severity of the disease, and is the leading cause of acute wheezing or hospitalization (<xref rid="B11" ref-type="bibr">11</xref>&#8211;<xref rid="B13" ref-type="bibr">13</xref>). Other pieces of evidence that link HDM and asthma include the fact that inhalation of HDM allergens induces the proliferation of bronchial smooth muscle (<xref rid="B14" ref-type="bibr">14</xref>), and that HDM-specific IgE were detected in the sputum of asthmatics (<xref rid="B15" ref-type="bibr">15</xref>).</p><p>The high percentage of HDM-mediated allergy encouraged extensive research on HDM allergens. An array of at least 30 allergen have now been identified for <italic toggle="yes">D. pteronyssinus</italic> (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). They are classified according to a Linnaean system for nomenclature based upon their genus, species, and the order they were discovered (<xref rid="B18" ref-type="bibr">18</xref>). For example, Der p 1 was the first discovered allergen from the genus <italic toggle="yes">Dermatophagoides</italic>, species <italic toggle="yes">pteronyssinus</italic> (<xref rid="B19" ref-type="bibr">19</xref>). Originally, HDM allergens were classified into major and minor groups based on their allergenicity and strict IgE reactivity. The major group allergen Der p 1 and Der p 2, and minor group allergen Der p 4, Der p 5 and Der p 7 account for ~50 and 30% of HDM-specific IgE, respectively (<xref rid="B17" ref-type="bibr">17</xref>). Thus, these major groups are serodominant (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>), while other groups have less clinical relevance (<xref rid="B21" ref-type="bibr">21</xref>&#8211;<xref rid="B23" ref-type="bibr">23</xref>). More recently, Der p 23, a peritrophin-like protein, has been identified as another major HDM allergen of <italic toggle="yes">D. pteronyssinus</italic> (<xref rid="B24" ref-type="bibr">24</xref>&#8211;<xref rid="B27" ref-type="bibr">27</xref>). Although Der p 23 is only present in low amounts in house dust and in HDM extracts, it was shown to induce IgE-dependent basophil activation which indicated a high allergenic activity (<xref rid="B28" ref-type="bibr">28</xref>). A recent study analyzed the profile of sensitization to HDM major components. The authors found that most individuals in the pediatric population with respiratory allergy disease with mite allergy are sensitized and contained IgE specific to Der p 1, Der p 2, and Der p 23 major allergens (<xref rid="B29" ref-type="bibr">29</xref>). The clinical relevance Der p 23 was further established by the fact that 5% of this population was mono-sensitized to Der p 23 and presented clinical symptoms of HDM allergy (<xref rid="B29" ref-type="bibr">29</xref>).</p><p>Nowadays, the complexity of HDM components and their mechanism of action led to an updated classification that matches their biological activity and regulatory effects on the epithelial cells, and cells of the innate and adaptive immune systems. <italic toggle="yes">D. pteronyssinus</italic> have allergens that exhibit proteolytic activity, homology with the lipopolysaccharide-binding component of Toll-like receptor 4, homology with other invertebrate tropomyosins, and chitin-cleaving and chitin-binding activity (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). The major allergens of <italic toggle="yes">D. pteronyssinus</italic> are listed in <xref rid="T1" ref-type="table">Table 1</xref>.</p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>HDM allergens derived from <italic toggle="yes">Dermatophagoides pteronyssinus</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Allergens</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Biological functions</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 1</td><td valign="top" align="left" rowspan="1" colspan="1">Cysteine protease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 2</td><td valign="top" align="left" rowspan="1" colspan="1">Lipid binding</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 3</td><td valign="top" align="left" rowspan="1" colspan="1">Serine protease (trypsin)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 4</td><td valign="top" align="left" rowspan="1" colspan="1">Amylase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 5</td><td valign="top" align="left" rowspan="1" colspan="1">Lipid binding</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 6</td><td valign="top" align="left" rowspan="1" colspan="1">Serine protease (chymotrypsin)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 7</td><td valign="top" align="left" rowspan="1" colspan="1">Lipid binding</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 8</td><td valign="top" align="left" rowspan="1" colspan="1">Glutathione transferase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 9</td><td valign="top" align="left" rowspan="1" colspan="1">Serine protease (collagenase)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 10</td><td valign="top" align="left" rowspan="1" colspan="1">Muscle tropomyosin</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 11</td><td valign="top" align="left" rowspan="1" colspan="1">High molecular weight muscle paramyosin</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 12</td><td valign="top" align="left" rowspan="1" colspan="1">Homology to chitin</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 13</td><td valign="top" align="left" rowspan="1" colspan="1">Lipid transfer</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 14</td><td valign="top" align="left" rowspan="1" colspan="1">Lipid transport</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 15</td><td valign="top" align="left" rowspan="1" colspan="1">Chitinase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 16</td><td valign="top" align="left" rowspan="1" colspan="1">Gelsolin</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 17</td><td valign="top" align="left" rowspan="1" colspan="1">EF hand protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 18</td><td valign="top" align="left" rowspan="1" colspan="1">chitin-binding protein</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 20</td><td valign="top" align="left" rowspan="1" colspan="1">Arginine kinase</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 21</td><td valign="top" align="left" rowspan="1" colspan="1">Putative fatty acid binding</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Der p 23</td><td valign="top" align="left" rowspan="1" colspan="1">Peritrophin, chitin binding</td></tr></tbody></table></table-wrap></sec><sec id="s3"><title>Airway Epithelium: the Initiator and Regulator of HDM-Mediated Allergic Asthma</title><p>Initial interactions with immunological sentinels start when HDM allergens reach and interact with the airway epithelial cells and immune cells resident in the airway lumen (<xref ref-type="fig" rid="F1">Figure 1</xref>). Increasing evidence demonstrates that asthma is an epithelial cells disorder and that its clinical manifestations are associated with compromised epithelial integrity (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Epithelial cells are joined by tight junction protein complexes which act as a fence to avert the passage of exogenous molecules and microbes from the airway lumen into the blood. The proteolytic activity of HDM allergens, which is limited to a distinct part of the allergome, is what makes them powerful. Although HDM harbor a repertoire of allergens with protease activity, those of group 1 or initiator (e.g., Der p 1) are the chief responsible for activating the innate immune response and facilitating polysensitization to allergens from unrelated sources (<xref rid="B34" ref-type="bibr">34</xref>).</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Overview of mucosal immune cells, molecules, and pathways targeted by house dust mite proteins to promote allergic asthma. The main allergen of house dust mite (HDM) is Der p 1, a cysteine protease. In addition to being an antigen, Der p 1 promotes allergic asthma through its action on a number of immune cells and molecules. Thus, Der p 1 can cleave tight junction proteins of epithelial cells and gain access to immune cells including na&#239;ve dendritic cells. It can also activate protease sensitive receptors (PARs) and TLR4, or promote cell injury in epithelial cells. This will result in the activation of NLRP3 inflammasome and secretion of cytokines and chemokines that recruit myeloid cells including dendritic cells, eosinophils, and ILC2. Cleavage of CD40 limits the production of IL-12 and IFN&#947; and thus, favors the polarization of Th2 cells. Der p 1 enhances the production of IgE though cleavage of CD23 receptor, which disrupts the negative feedback for regulation of IgE production. Finally, cross-linking of Der p 1-specific IgE on mast cells by Der p 1 mediates mast cell degranulation and release of histamine and other mediators associated with the symptoms of the allergic asthma.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-11-534501-g0001.jpg"/></fig><p>Inhibition of Der p 1 proteolytic activity abolished allergic sensitization in mice challenged intranasally with HDM (<xref rid="B35" ref-type="bibr">35</xref>). In fact, the protease activity of Der p 1 targets tight junction proteins such as Occludin and Claudins and thus, increases the barrier permeability of the airway mucosa (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>) and subsequent influx of allergens (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B38" ref-type="bibr">38</xref>). Other groups of HDM allergens are triad of serine proteases (Der p 3, Der p 6, and Der p 9) that exhibit sequence homology to trypsin, chymotrypsin, and collagenase, respectively (<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>). Serine proteases cleave tight junction proteins and exhibit redundancy with group1 in their functionality, thus their role in allergic sensitization is subordinate (<xref rid="B35" ref-type="bibr">35</xref>).</p><p>Winton et al. used five cell lines to study the effects of proteinases on epithelial permeability (<xref rid="B41" ref-type="bibr">41</xref>). Intriguingly, HDM proteinases of both cysteine and serine classes were able to perturb epithelial cells adhesion and function (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). However, the cell cultures were performed in the absence of serum and cells could lack essential growth factors required for expression and function of intercellular junctions and the cytoskeleton. Thus, a challenge in working with epithelial cell lines <italic toggle="yes">in vitro</italic> appears to be insuring the provision of an environment in which airway epithelial cells will optimally express the desired characteristics, and a normal repertoire of functional intercellular adhesion molecules. In fact, significant discrepancy can occur between crude measurements of &#8220;epithelial leakiness&#8221; (uncorrected solute clearance) and more precise measures of permeability under conditions where changes in physiological function occur. Furthermore, experiments performed in serum free media do not account for factors that can limit the activity of HDM proteases, <italic toggle="yes">in vivo</italic>.</p><p>Zhang et al. used specific inhibitors of proteases including serine proteases and cysteine proteases, to elucidate the enzymatic activities of Der p 1 that played a major role in allergic sensitization (<xref rid="B42" ref-type="bibr">42</xref>). These studies have shown that the serine proteases of Der p1, or the closely related Der f 1 (a major allergen of <italic toggle="yes">D. farinae</italic>), only play a minor role in allergic sensitization. On the other hand, the cysteine peptidase activity of Der p 1 is central to the initiation of allergy because its bioactivity mediated both the degradation of tight junctions and the polarization of immune responses toward Th2-type. Thus, the cysteine peptidase activity Der p 1 favors both allergen delivery and IgE production (<xref rid="B42" ref-type="bibr">42</xref>). However, the unrestrained contribution from HDM serine peptidase allergens is insufficient to drive these responses when Der p 1 is inhibited. Thus, endogenous serine peptidase inhibitors which are known to be vulnerable to degradation by Der p 1 (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>) provide protection against them when the activity of Der p 1 is inhibited. In fact, Der p 1 is an enabler/initiator of allergy to unrelated proteins as it provides a means to cross the epithelial layer and overcome mucosal tolerance.</p><p>Previous studies have shown that Der p 1 facilitates sensitization to ovalbumin and that the potentiation of allergenicity is dependent on the protease activity of Der p 1 (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Although it is capable of initiating IgE synthesis, ovalbumin differs markedly from Der p 1 as the former requires an adjuvant to overcome tolerance when delivered to the airways. Therefore, the protease activity of Group 1 HDM must act similarly for unrelated allergens of mite origin. The adjuvant effect of Group 1 HDM allergens on the overall sensitization to HDM allergens is only one example of their ability to promote allergic responses to bystander allergens of non-HDM origin. Therefore, it is possible that the serine proteases alone lack the adjuvant activity needed to overcome the immunological tolerance toward antigens delivered into the airways.</p><p>Even though HDM proteases cleave tight junction proteins, desmosomal adhesion are examples of junctions that are not a primary cleavage target of HDM proteases (<xref rid="B36" ref-type="bibr">36</xref>). Cleavage of tight junction proteins by HDM proteases is one mode by which they compromise epithelial permeability. Other indirect effects of HDM allergens include decreased expression of tight junction proteins (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B47" ref-type="bibr">47</xref>).</p><p>Beside physical defenses provided by epithelial cells, the airway surface liquid is rich in antiprotease molecules such as &#945;1-antitrypsin, which display a new facet of interactions with protease allergens. Thus, in general, allergen serine proteases are inhibited by &#945;1-antitrypsin. However, when the mite feces reach the lower airways, Der p 1 inhibit the anti-protease-based lung defense by cleaving the &#945;1-antitrypsin (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Interestingly, Der p 1 by itself is resistant to most antiproteases (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Furthermore, Der p 1 degrades pulmonary surfactants (SP-A and SP-D) in the airway surface liquid that would normally bind inhaled allergens and prevent them from reaching IgE bound to mast cells (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>).</p><p>Since HDM are ubiquitous in the environment and can be found as contaminants in food, several groups investigated the effect of HDM on the gastrointestinal (GI) tract. Thus, ingestion of contaminated food can lead to intestinal inflammation (<xref rid="B50" ref-type="bibr">50</xref>). Tulic et al. detected Der p 1 in the intestinal fluid of asthmatic patients and its concentration gradually decreased along the GI tract with higher concentration in the duodenum and the lowest in the colon (<xref rid="B51" ref-type="bibr">51</xref>). HDM was also reported to impair intestinal barrier function and increase intestinal permeability by reducing the expression of tight junction proteins such as zonula occludens protein 1 (ZO-1) and occludin-1, as well as the production of mucus (<xref rid="B51" ref-type="bibr">51</xref>). Cysteine protease activity of HDM induced pro- and anti-inflammatory cytokines, and it was aggravated in the inflammatory bowel disease (IBD) patients (<xref rid="B51" ref-type="bibr">51</xref>). It remains unclear how ingestion of HDM could impact allergic sensitization to HDM or allergic responses upon exposure to HDM via the airways.</p></sec><sec id="s4"><title>Innate Responses Induced by HDM Allergens</title><p>In addition to cleaving tight junctions and compromising epithelial cell permeability, dust mite proteases orchestrate a series of signaling events within the sphere of innate immunity (<xref ref-type="fig" rid="F1">Figure 1</xref>). Innate immunity is a highly sophisticated system of defense mediated by immune cells in responses to signals they receive through a variety of pattern recognition receptors (PRRs). Whether they are extracellular or intracellular, PRRs sense pathogen-associated molecular patterns (PAMPs) (e.g., LPS, chitin) and danger-associated molecular patterns (DAMPs) (e.g., uric acid, ATP) that are released during tissue injury (<xref rid="B52" ref-type="bibr">52</xref>). Extended epithelial PRRs activation by allergens or via microbial PAMPs contaminants represent one of the central steps in Th2-mediated sensitization which results in the release of proinflammatory cytokines and chemokines, thus amplifying the influx of Th2 cells, DCs, eosinophils, basophils, and other inflammatory cells (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>). Further, released cytokines activate innate immune cells such as basophils, mast cells, eosinophils and group 2 innate lymphoid cells (ILC2) to sustain the Th2-mediated inflammation (<xref rid="B55" ref-type="bibr">55</xref>). Stimulated ILC2 release Th2 cytokines such as IL-13 and IL-5 (<xref rid="B55" ref-type="bibr">55</xref>). Therefore, Th2-mediated response is a result of complex crosstalk between the epithelium and cells of the innate and adaptive immunity.</p><sec><title>Stimulation of Protease-Activated Receptors (PARs)</title><p>In addition to increasing epithelial cell permeability, dust mite proteases stimulate protease-activated receptors (PARs) in the bronchial epithelium of asthmatics (<xref rid="B56" ref-type="bibr">56</xref>). Unexpectedly, Der p 1 has been shown to exhibit prothrombinase activity, thus converting prothrombin to thrombin (<xref rid="B57" ref-type="bibr">57</xref>). Canonical activation of PAR-1 and PAR-4 is mediated via HDM serine proteases such as Der p 3, or Der p 9. However, non-canonical activation of these receptors by Der p1 through its prothrombinase activity promoted release of reactive oxygen (ROS), nitrogen species (RNS), respectively (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B57" ref-type="bibr">57</xref>). Even though serine proteases are the candidates for activation of PARs, selective inhibition of Der p 1 attenuated production of reactive species. This suggests that Der p 1 is the main allergen stimulating the release of these reactive species. Downstream activation of PAR-1 and PAR-4 by Der p 1-thromin axis result in pannexons opening leading to release of ATP (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). ATP is considered a DAMP that activates A disintegrin of metalloproteases 10 (ADAM 10), thus mediating the production of ROS (<xref rid="B58" ref-type="bibr">58</xref>). In the airway epitheilal cells, ADAM 10 initates further conversion of prothrombin to thrombin downstream of the prothrombinase activity of Der p 1, thus positively feedback ROS production (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>). Consistently, ATP and thrombin levels are elevated in asthma (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>). The fact that Der p 1 mediated innate ROS production through a thrombin dependent mechanism sheds new light on how allergens directly influence the development of Th2-biased immune responses (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). Importantly, other studies have reported an imbalanced reducing and oxidizing (redox) environment favoring oxidation is present in asthma (<xref rid="B63" ref-type="bibr">63</xref>). Such an oxidative environment could modify proteins and alter their biological functions needed for initiation and maintenance of inflammation. This can include the loss of antioxidant capacity of the superoxide dismutase (SOD) that catalyzes the reaction of superoxide to hydrogen peroxide and the transformation of hydrogen peroxide into water (<xref rid="B63" ref-type="bibr">63</xref>).</p><p>Cunningham et al. examined the importance of the cysteine protease activity by activating papain, a plant cysteine proteases, that is homologous to Der p 1. Papain was activated through reduction with L-cysteine, and compared with the non-reduced papain for their ability to induce allergic inflammation (<xref rid="B64" ref-type="bibr">64</xref>). Challenge with the activated papain markedly increased IgE and IgG1 antibody responses as well as in eosinophilia and IL-4, IL-5, and IL-10 in the BAL of mice. Further, the enzymatic activity of low doses of cysteine protease allergens administered to the respiratory mucosa drive Th2 immune responses that can mediate fulminant lung hypersensitivity responses and persist in the face of ongoing exposure. Therefore, it is essential for Der p 1 to be activated by reduction in order to overcome the oxidative environment in the lungs and mediate allergic sensitization. Generated reactive species induce histone modifications and the activation of redox-sensitive transcription factors which promote pro-allergic cytokines. They further activate signaling pathways such as mitogen-activated protein kinases (MAPK), and the signal transducer and activation of transcription (STAT) family that is associated with allergy and asthma (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). In addition, epithelilal ROS production modulates the release of IL-33, a pivotal cytokine that acts on ILC2 to promote a Th2-biased response by dendritic cells (<xref rid="B67" ref-type="bibr">67</xref>). Although humans are continuously exposed to HDM allergens, only a subset of the population become sensitized. People at higher risk of sensitization to HDM allegens exhibit genetic defect in the antioxidant defenses or in the susceptibility to ROS/RNS which are triggered by the innate cellular responses to these allergens (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>). Indeed, the antioxidant enzymes superoxide dismutases (SOD) and catalase are reduced in asthma as compared to healthy individuals, with lowest levels in those patients with the most severe asthma (<xref rid="B63" ref-type="bibr">63</xref>).</p><p>Further, HDM allergen-mediated PARs activation promotes the release of pro-Th2 cytokines and chemokines including IL-6, IL-8, and GM-CSF in cultured airway epithelial cells. These cytokines and chemokines trigger the extravasation and accumulation of eosinophils, basophils, and neutrophils, which perpetuate the allergic inflammation of the airways (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B70" ref-type="bibr">70</xref>&#8211;<xref rid="B76" ref-type="bibr">76</xref>). Moreover, activation of PARs by peptide agonist that mimics PARs ligands induce the release of cytokines suggesting that, at least the serine proteases promote the allergic response via induction of cytokine release (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B76" ref-type="bibr">76</xref>). One of the PAR family receptor, PAR-2 is upregulated by airway epithelium, and its expression correlated with asthma severity and airway smooth muscle enlargement (<xref rid="B77" ref-type="bibr">77</xref>&#8211;<xref rid="B79" ref-type="bibr">79</xref>). Several lines of evidence indicate that activation of PAR-2 plays a key role during the sensitization phase of the HDM allergy model, leading to increased lung cytokine production and augmented lung reactivity (<xref rid="B80" ref-type="bibr">80</xref>). First, PAR-2 deficient mice sensitized and challenged with HDM fail to develop airway inflammation and HDM-specific IgG1. Second, blocking PAR-2 activation diminishes Th2-mediated cytokines, airway hyperresponsiveness, and airway inflammation in response to HDM challenge (<xref rid="B80" ref-type="bibr">80</xref>). Third, PAR-2 activation contributes to the development of IgE response, thus promoting adaptive immunity to HDM (<xref rid="B81" ref-type="bibr">81</xref>). However, studies demonstrated that release of cytokines by epithelial cells in response to Der p 1 is PAR-2 independent (<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B74" ref-type="bibr">74</xref>). Even though, PAR-2 is involved in the response to HDM allergens; it was shown that PAR-2 is dispensable for allergy development by inhaled route in PAR-2 deficient mice (<xref rid="B81" ref-type="bibr">81</xref>). In addition, PAR-2 inhibit eosinophilia, airway hyperresponsiveness and bronchoconstriction in a murine model of allergic inflammation (<xref rid="B82" ref-type="bibr">82</xref>), or enhances airway inflammation and airway hyperresponsiveness (<xref rid="B72" ref-type="bibr">72</xref>). Therefore, PAR-2 can exert cytoprotective or inflammatory effects based on the circumstances.</p></sec><sec><title>Activation of TLR4</title><p>Toll-like receptor 4 (TLR4) is one member of the TLR family that is expressed on airway epithelial cells and has drawn attention in the context of allergy due to its ability to bind LPS. LPS from Gram-negative bacteria is the most studied PAMP and considered as contaminant of HDM allergens. The importance of TLR4 in HDM-mediated allergy was shown through epidemiological and mechanistic studies. Epidemiological studies demonstrated that high LPS dose is detrimental in allergic sensitization and development of asthma, which is inversely proportional with the level of LPS contained in the HDM (<xref rid="B83" ref-type="bibr">83</xref>, <xref rid="B84" ref-type="bibr">84</xref>). Low doses of LPS promote Th2 response and eosinophilic inflammation while high doses mediate Th1 response and neutrophilic inflammation (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>). Elegant mechanistic studies revealed that the expression and triggering of TLR4 on epithelial cells are indispensable for sensitization to HDM allergens (<xref rid="B87" ref-type="bibr">87</xref>&#8211;<xref rid="B89" ref-type="bibr">89</xref>). The link between TLR4 activation by contaminating LPS and HDM sensitization was established by showing that LPS promoted IL-1&#945; release (<xref rid="B88" ref-type="bibr">88</xref>). Secreted IL-1&#945; alarmin targets epithelial cells in an autocrine manner, to release GM-CSF and IL-33 which recruits dendritic cells (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B88" ref-type="bibr">88</xref>), and neutralization of these triad cytokines dampens allergy development (<xref rid="B88" ref-type="bibr">88</xref>). Importantly, release of IL-33 is ROS-regulated by NADPH oxidase dual oxidase 1 (DUOX1) whose activity is elevated in allergic disease (<xref rid="B90" ref-type="bibr">90</xref>). Further, ablation of TLR4 on epithelial cells or inhibition through antagonists reduced recruitment and activation of sub-epithelial DCs and suppressed features of asthma such as bronchial hyperreactivity (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B88" ref-type="bibr">88</xref>). In addition, knockout mice in <italic toggle="yes">TLR4</italic> and <italic toggle="yes">MyD88</italic> are attenuated in Th2 cytokines, IL-17, neutrophilia, and bronchial hyperreactivity compared to WT (<xref rid="B91" ref-type="bibr">91</xref>&#8211;<xref rid="B94" ref-type="bibr">94</xref>). These data indicated that HDM, specifically LPS regulate Th2 and Th17 associated with lung inflammation. Even though inhibition of the activated cysteine protease inhibited (but did not abolish) most of sensitization, responses could be still dependent on TLR4 especially under chronic exposure of low dose allergens.</p><p>Several studies have shown a crucial role of TLR4 in sensitization to aero-allergens (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B87" ref-type="bibr">87</xref>) and especially in sensitization to Der p 2 (<xref rid="B20" ref-type="bibr">20</xref>) via the broncho epithelial route. The central role of TLR4 in HDM sensitization was shown to be dependent upon group 2 allergens such as Der p 2, which exhibit similarity to myeloid differentiation antigen-2 (MD-2), a TLR4 co-receptor (<xref rid="B20" ref-type="bibr">20</xref>). It was thought that MD-2 mimicry could compensate for the lack of MD-2 expression in the epithelial cells, thus establishing a mechanistic link to the role of LPS in allergy. Indeed, MD-2 expression in cultured primary epithelial cells is associated with increased responsiveness to LPS (<xref rid="B95" ref-type="bibr">95</xref>). Trompette et al. used a model of sustained hypersensitivity to assess the role of TLR4 and MD-2 receptor in allergic sensitization. The authors used intranasal injections for 21 days to address whether the induction of asthma by Der p 2 is TLR4- and MD-2 dependent (<xref rid="B20" ref-type="bibr">20</xref>). Initial assessment of the involvement of TLR4 and MD-2 in Der p 2 mediated signaling was performed <italic toggle="yes">in vitro</italic> using HEK293 cells. Trompette et al. showed that the mutation of tyrosine to alanine (Y91A) ablated the ability of Der p 2 to reconstitute LPS-driven IL-8 production in HEK293 cells expressing TLR4 without MD-2, or to augment LPS-driven IL-8 production in HEK293 cells co-expressing TLR4 and MD-2. Thus, in HEK293 cells, Der p 2 promotes LPS-induced TLR4 signaling in a manner that appears to depend on Der p 2 and TLR4 interactions. Sensitization and challenge with Der p 2, along with extremely low (pg range) of LPS, induced robust airway Th2 inflammation-marked by airway eosinophilia and lymphocytosis, mucous metaplasia, and increased plasma IgE concentrations in wild type but not TLR4-deficient mice. Notably, Der p 2 similarly induced Th2 inflammation in the airways of MD-2-deficient mice. On the other hand, mutant Der p 2(Y91A) failed to induce experimental allergic asthma. Thus, <italic toggle="yes">in vivo</italic> allergenic activity mirrors <italic toggle="yes">in vitro</italic> functional and biochemical activity: Der p 2 efficiently drives airway Th2 inflammation <italic toggle="yes">in vivo</italic> in a TLR4-dependent manner, and retains the ability to drive such inflammation in the absence of MD-2. Mutations in LPS that would abrogate the binding to TLR4 would reduce the allergic sensitization.</p><p>In contrast to data generated for the lung, Stremnitzer et al. showed that TLR4 does not account for sensitization to Der p 2 in the skin (<xref rid="B96" ref-type="bibr">96</xref>). Indeed, TLR4<sup>&#8722;/&#8722;</sup> mice showed an even stronger overall Th2-biased antibody response to epicutaneous Der p 2 than WT mice receiving the same treatment. In contrast to lung models (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B87" ref-type="bibr">87</xref>), sensitization to Der p 2 was even more pronounced in TLR4<sup>&#8722;/&#8722;</sup> mice if LPS was present. Therefore, Der p 2 alone can cause a strong Th2-biased response via the skin, which is further enhanced in the presence of LPS, in TLR4-independent manner. Furthermore, TLR4 expression does not enhance but rather protect against epicutaneous sensitization to house dust mite allergen Der p 2. These findings suggest that the skin is an important sensitization route that may differentially modulate immune responses to allergens than after exposure via the bronchial epithelium. In this regard, functional TLR4 might have a protective function against skin allergens. It is also possible that the response unaffected by the cysteine protease would become important with low dose chronic exposure experienced by humans.</p><p>Importantly, group 2 allergens exhibit hydrophobic pocket capable of binding LPS and potentially bind to lipids other than LPS and activate other TLRs. However, the indispensability for TLR4 in HDM sensitization and allergy does not seem to be merely dependent on MD-2 mimicry for several reasons. First, group 2 allergens do not induce ROS production and have no direct effect on the epithelium unless they are administered in conjunction with group 1 HDM allergens. Second, selective inhibition of Der p 1 proteolytic activity abolishes signs of allergic sensitization in mice, an effect that is hard to associate with the importance of TLR4 being absolutely dependent on MD-2 mimicry (<xref rid="B35" ref-type="bibr">35</xref>). More insight into the role of TLR4 in HDM-mediated allergy was obtained by showing that TLR4 activation by HDM mediates ROS production is Der p 1-dependent (<xref rid="B42" ref-type="bibr">42</xref>). Der p 1 mediates TLR4 activation by putative endogenous ligands such as fibrinogen (<xref rid="B97" ref-type="bibr">97</xref>), and selective inhibition of Der p1 abolished ROS production (<xref rid="B34" ref-type="bibr">34</xref>). The Der p 1-dependent activation of TLR4 is an outcome of signaling events initiated by its activation of PAR-1 and PAR-4. The authors show that TLR4 ligation to ROS production occurs downstream from the gating of pannexons and endogenous activation of prothrombin (<xref rid="B42" ref-type="bibr">42</xref>). Therefore, stimulation of PRRs by HDM plays a pivotal role in allergic sensitization and development of asthma. Even though Der p 1 and Der p 2 have been studied in the context of innate immune stimulation through TLRs, putative interactions of other HDM allergens with PPRs need to be elucidated.</p></sec><sec><title>Activation of NOD-Like Receptors (NLRs)</title><p>The cytosolic NOD-like receptors (NLRs) protein family such as NLRP3 or NLRC4 sense PAMPs or DAMPs. Pattern sensing is followed by nucleation and oligomerization of the adaptor protein ASC (apoptosis-associated speck like protein containing CARD), the engagement of the cysteine protease pro-caspase-1, and formation of the multiprotein inflammasome complex (<xref rid="B98" ref-type="bibr">98</xref>&#8211;<xref rid="B100" ref-type="bibr">100</xref>). Canonically within the oligomerized inflammasome complex, dimers of pro-caspase-1 undergo proteolytic auto-cleavage into the enzymatically active caspase-1, which consequently catalyzes the final processing of the inflammatory cytokines pro-IL-1&#946; and pro-IL-18 precursors into their mature and secreted forms (<xref rid="B101" ref-type="bibr">101</xref>). To date, contradictory results were obtained regarding the role of NLRP3 in HDM-mediated allergy and the role of other NLRs in asthma is poorly understood. Early studies showed that NLRP3 is dispensable for HDM-induced allergic airway inflammation (<xref rid="B102" ref-type="bibr">102</xref>). Intranasal challenge with HDM extract promoted uric acid release, a prototypic activator of the NLRP3 inflammasome (<xref rid="B103" ref-type="bibr">103</xref>). Intriguingly, uric acid is elevated in asthma patients and has been shown to promote Th2 allergic inflammation in response to HDM (<xref rid="B102" ref-type="bibr">102</xref>). The adjuvant effect of uric acid is independent of NLRP3-ASC-IL-1-MyD88 axis, but associated with activating dendritic cells via spleen tyrosine kinase and PI3-kinase &#948; signaling (<xref rid="B102" ref-type="bibr">102</xref>). However, recent study showed that the NLRP3 complex modulates HDM-induced inflammation by controlling eosinophil influx, and Th2 cytokines and chemokines in the airways of mice. Therefore, <italic toggle="yes">NLRP3</italic><sup>&#8722;/&#8722;</sup> mice exhibit increased airway inflammation in response to HDM, which is associated with augmented immune cell infiltration specifically eosinophils; Th2 cytokines and chemokines in their airways (<xref rid="B104" ref-type="bibr">104</xref>). This study further demonstrated that mice lacking <italic toggle="yes">caspase-1</italic> exhibit robust lung inflammation characterized by eosinophilia and an increase in IL-33, TSLP, and IL-25 cytokines (<xref rid="B104" ref-type="bibr">104</xref>). Augmented lung inflammation is attributed to increased expression of IL-33, uric acid and spleen tyrosine kinase production (<xref rid="B105" ref-type="bibr">105</xref>). In addition to lacking caspase-1, mice used in this study are also deficient in caspase-11, another cysteine protease that is related to caspase-1 and activated non-canonically (<xref rid="B106" ref-type="bibr">106</xref>). Therefore, it is not known whether the observed phenotypes are attributed to the lack of caspase-1 or caspase-11 or both.</p><p>Caspase-11 or (caspase-4/5 in humans) belongs to the family of inflammatory caspases that share homology with caspase-1 (<xref rid="B107" ref-type="bibr">107</xref>&#8211;<xref rid="B114" ref-type="bibr">114</xref>). Caspase-11 participates in the activation of the NLRP3 inflammasome and mediates pyroptotic cells death that is associated with the release of inflammatory IL-1&#946; and IL-18 in response to non-canonical stimuli (<xref rid="B106" ref-type="bibr">106</xref>, <xref rid="B115" ref-type="bibr">115</xref>&#8211;<xref rid="B117" ref-type="bibr">117</xref>). While caspase-1 is constitutively expressed, caspase-11 expression is induced through LPS-activated TLR4 signaling via the adaptor TIR-domain-containing adaptor-inducing interferon-&#946; (TRIF) and TRIF-dependent type I interferon production (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B106" ref-type="bibr">106</xref>, <xref rid="B118" ref-type="bibr">118</xref>). However, the roles of caspase-11 in HDM-mediated asthma need to be elucidated.</p><p>HDM-mediated allergy has a significant reliance on bioactive constituents acting in synergy to produce their biological effects. However, commercial extracts can vary in their composition which affects their bioactivity profiles. Therefore, the conflicting results regarding the role of NLRP3 in HDM-mediated allergy could arise from using different HDM extracts, dosage, route and length of HDM challenge. In the ovalbumin model, absence of NLRP3 was associated with reduced allergic inflammation in the presence or absence of aluminum hydroxide (alum) adjuvant (<xref rid="B119" ref-type="bibr">119</xref>, <xref rid="B120" ref-type="bibr">120</xref>). The difference seen between HDM and ovalbumin could account for the difference in antigenicity which is associated with different cytokines that are involved in aggravating the airway inflammation (<xref rid="B104" ref-type="bibr">104</xref>).</p><p>Two independent studies have shown that caspase-11-deficient mice are resistant to developing experimental allergic airway inflammation in response to two different allergens. Using HDM, we showed a global reduction in inflammation in the lungs of <italic toggle="yes">caspase-11</italic><sup>&#8722;/&#8722;</sup>. This reduction is manifested by reduced cellular infiltration including neutrophils, macrophages and lymphocytes in the lungs. We also observed reduced Th1, Th2, and Th17 cytokines in the broncho-alveolar lavage fluid derived from <italic toggle="yes">caspase-11</italic><sup>&#8722;/&#8722;</sup> mice (Abu Khweek et al., under review). The reduced lung inflammation in <italic toggle="yes">caspase-11</italic><sup>&#8722;/&#8722;</sup> could be due to increased level of IgA, which potentially neutralizes HDM in our experimental model. It can also be due to reduced migration of neutrophils to the lungs in response to lower levels of KC and IL-17A. Alternatively, it may be due to reduced IL-33 that can lead to reduced IL-4 and IL-5 production by T cells. Our study offers several intriguing scenarios for the diverse functions of caspase-11. Expression of caspase-11 in innate immune cells following HDM exposure may be required for the antigen presentation by macrophages and dendritic cells to na&#239;ve T cells. Subsequently, insufficient antigen presentation leads to reduction in cytokines and chemokines released in the BAL fluids. Our published work and that of others also support the notion of inherent defect in migration of <italic toggle="yes">caspase-11</italic><sup>&#8722;/&#8722;</sup> cells due to impaired actin cytoskeleton (<xref rid="B121" ref-type="bibr">121</xref>, <xref rid="B122" ref-type="bibr">122</xref>). Zaslona et al. showed that <italic toggle="yes">caspase-11</italic><sup>&#8722;/&#8722;</sup> mice injected and challenged with ova plus alum are resistant to developing allergic airway inflammation. The reduced inflammation is associated with lessened infiltration of leukocytes to the lungs, especially eosinophils. In addition, <italic toggle="yes">caspase-11</italic><sup>&#8722;/&#8722;</sup> mice showed reduced release of Th2, Th1, Th17 cytokines, and circulating IgE (<xref rid="B123" ref-type="bibr">123</xref>). Even though we used a different allergen, exposure time and routes of administration, the findings by Zaslona are in line with several of our data. Taken together, these studies demonstrate that caspase-11 activity is important for the induction of allergic asthma.</p></sec><sec><title>Interactions With ILCs</title><p>Group 2 innate lymphoid cells are a recently discovered innate immune cells that are closely related to allergen responses as these cells produce the same cytokines as Th2 cells (<xref rid="B124" ref-type="bibr">124</xref>). They are the most predominant ILC population in the lungs at steady state, and when activated they expand rapidly (<xref rid="B125" ref-type="bibr">125</xref>). Also, according to experiments performed by Smith et al., the number of ILC2s is higher in the peripheral blood mononuclear cells (PBMC) of allergic asthma patients when compared to healthy donors, and even donors with allergies but no asthma (<xref rid="B126" ref-type="bibr">126</xref>). In general, ILC2s are activated by IL-33, IL-25, and thymic stromal lymphopoietin (TSLP) which induce them to rapidly expansion and produce IL-4, IL-5, and IL-13 (<xref rid="B124" ref-type="bibr">124</xref>). This is however contrasted by the way that ILC2s seem to react in cases of HDM exposure. Thus, it was suggested that T cells are necessary for complete ILC2 function in an HDM model of allergic asthma in mice (<xref rid="B127" ref-type="bibr">127</xref>). While underlying mechanisms are not fully understood, this report further illustrates the complexity of the HDM allergic asthma model, and the interconnectedness of the innate and adaptive immunity in this complex disease scenario.</p></sec><sec><title>Regulation of Myeloid and Epithelial Cells</title><p>Beyond the disruption of major junctional adhesions of epithelial cells, the proteases released by HDM facilitate allergens access to submucosal tissues and their detection by APCs such as dendritic cells (DCs) (<xref rid="B128" ref-type="bibr">128</xref>). Recruitment of APCs at mucosal surfaces and their departure for interaction with naive T cells is instrumental in bridging innate and adaptive immune signaling to allergens. It is now appreciated that the role of DCs is beyond sensitization to HDM allergens. In fact, DCs are fundamental in instructing humoral and Th2-mediated responses and their increased functionality could be proportional to epithelium permeability (<xref rid="B128" ref-type="bibr">128</xref>). Moreover, differentiation of na&#239;ve T cell into Th1, Th2, or Th17 is dependent upon DCs- derived cytokines (<xref rid="B128" ref-type="bibr">128</xref>). Der p 1 promotes migration of DCs into the bronchial epithelial in response to production of chemokine C-C ligand 2 (CCL2), CCL5, CCL20, and CXCL10 by bronchial epithelial cells (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B129" ref-type="bibr">129</xref>). The release of CCL20 is Der p 1- and TLR4-dependent (<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B87" ref-type="bibr">87</xref>). In addition, stimulation of the epithelial airways by HDM allergens and release of CCL20 could be induced via a non-Toll pathogen recognition receptor such as C-lectin (<xref rid="B130" ref-type="bibr">130</xref>). The induction of CCL20 secretion is specific for HDM, and no other aeroallergens, and is independent of TLR4/2 and proteases (<xref rid="B130" ref-type="bibr">130</xref>). Instead, secretion of CCL20 is mediated via ligation of &#946;-glucan moiety present in the HDM to the C- type lectin receptor dectin1 (<xref rid="B130" ref-type="bibr">130</xref>). Further demonstration that &#946;-glucan is the ligand inducing CCL20 by epithelial cells was shown through abrogation of HDM mediated release of CCL20 by &#946;-glucanase or competitive inhibition with &#946;-glucans. The relevance of C-lectin receptor to HDM-mediated allergy is reinforced by evidence that dectin-1 is critical for the development of HDM-induced influx of eosinophils, neutrophils into the lungs, and the generation of Th2 cytokines (<xref rid="B131" ref-type="bibr">131</xref>, <xref rid="B132" ref-type="bibr">132</xref>). Dectin-1 is specifically expressed on CD11b<sup>+</sup> DCs, an essential subset of DCs in allergic sensitization, but not on other DCs or lung epithelial cells. Dendritic cells elicit a superior capacity for antigen uptake and presentation that is attributed to expression of the C-lectin receptor dectin-1. Therefore, activation of this specific subset of DCs by HDM &#946;-glucan in the lung could couple innate and adaptive immunity (<xref rid="B132" ref-type="bibr">132</xref>). Moreover, stimulation of dectin-1 or mannose receptors by chitin, a repeating units of &#946;-(1&#8211;4)-poly-N-acetyl-D-glucosamine mediates Th1, Th2, and Th17 polarization as well as the recruitment of eosinophils and basophils (<xref rid="B133" ref-type="bibr">133</xref>, <xref rid="B134" ref-type="bibr">134</xref>). However, the molecular mechanisms by which chitin promote innate immunity need to be elucidated.</p><p>An large body of literature has focused on the direct injury caused by the protease activity of allergens, including damaging tight junctions and subsequent activation of the signaling pathways (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B135" ref-type="bibr">135</xref>, <xref rid="B136" ref-type="bibr">136</xref>). However, downstream of airway epithelial injury and initiation of signaling events, HDM allergens must directly interact with APCs, a key event to promote adaptive immunity. Allergens interactions with DCs are mediated via mannose receptor and DC-SIGN which belong to the C-lectin receptors. These receptors mediate uptake of glucan structure of Der p 1, Der p 2 resulting in Th2 polarization (<xref rid="B137" ref-type="bibr">137</xref>, <xref rid="B138" ref-type="bibr">138</xref>). In addition, Der p 1 downregulates the expression of tryptophan catabolizing enzyme, indoleamine 2,3-dioxygenease (IDO) in DCs (<xref rid="B137" ref-type="bibr">137</xref>). Immunomodulatory functions of IDO include the induction of regulatory T cells (Tregs) or the depletion of effector T cells, which have been shown to inhibit the development of asthma in mouse models (<xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B140" ref-type="bibr">140</xref>). Furthermore, downregulation of IDO by Der p 1 could inhibit immune tolerance and lead to development of allergic sensitization. Therefore, therapeutics designed to manipulate IDO activity could promote tolerance and inhibit allergic sensitization.</p></sec></sec><sec id="s5"><title>Adaptive Immunity to HDM</title><p>The high allergenicity of HDM proteases is also associated with their ability to mediate Th2 biased immune response by reducing Th1 polarization (<xref rid="B141" ref-type="bibr">141</xref>, <xref rid="B142" ref-type="bibr">142</xref>). Der p 1-mediated Th2 cell differentiation through IL-6 production by epithelial cells, and limiting innate signals required for Th1 differentiation (<xref rid="B143" ref-type="bibr">143</xref>). Der p 1 promotes Th2 biased proliferation by deconstructing the IL-2 receptor which is involved in mediating Th1 proliferation (<xref rid="B142" ref-type="bibr">142</xref>). In addition, compelling evidence indicate that the proteolytic activity of Der p 1 is instructional in directing DCs-mediated Th2 subset development. Therefore, Der p 1-promoted DCs activation induced Th2 polarization via reduced release of IL-12, a pivotal cytokine in Th1 polarization and differentiation (<xref rid="B144" ref-type="bibr">144</xref>). Der p 1-induced suppression of IL-12 production is due to cleavage of CD40, a co-stimulatory molecule expressed on APCs, thus rendering DCs less responsive to CD40-CD40L pathway (<xref rid="B144" ref-type="bibr">144</xref>). Furthermore, DCs that mature in presence of proteolytically active Der p 1 and reduce the release INF-&#947;, but increase production of IL-4 by CD4<sup>+</sup> T cells, thus promoting Th2 polarization (<xref rid="B144" ref-type="bibr">144</xref>). The resulting cytokine milieu again favors the polarization of na&#239;ve T cells into Th2 cells.</p><p>Effector functions of B cells include production of HDM-specific immunoglobulins, of which IgG, IgA, IgM, and IgE are released in response to allergens. Although IgE exerts a pathogenic function, allergen specific-IgA or IgG4 are thought to have protective functions by capturing and neutralizing allergens at mucosal surfaces (<xref rid="B145" ref-type="bibr">145</xref>&#8211;<xref rid="B147" ref-type="bibr">147</xref>). Further dimension to the pleotropic role of Der p1 was demonstrated via disrupting the negative feedback loop for IgE-production in B cells which eventually results in the progression of the allergic disease (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B148" ref-type="bibr">148</xref>). Der p 1 activates the signaling cascade associated with ADAM10, a &#8220;sheddase&#8221; of the low affinity IgE receptor, cluster of differentiation 23 (CD23) (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B149" ref-type="bibr">149</xref>). Proteolytic release of CD23 from cells is considered a key event in allergic asthma. Soluble CD23 promotes antigen presentation to allergen-specific B cells, thus mediating the formation of allergen-specific IgE. Excessive production of IgE inhibits the negative feedback mechanism that would otherwise restrict IgE production (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B148" ref-type="bibr">148</xref>).</p><p>Besides immunoglobulin production, B cells exhibit accessory roles in antigen presentation especially when T cells are initially primed by DCs following allergens capturing through the surface immunoglobulin receptor (<xref rid="B150" ref-type="bibr">150</xref>, <xref rid="B151" ref-type="bibr">151</xref>). Even though B cells are not as efficient in antigen presentation, their presence in T cell-inductive sites and production of cytokines that influence the activation of DCs and na&#239;ve T cells and their expression of costimulatory molecules such as CD80 and CD40 ligand equip B cells with antigen presenting and other accessory functions that are pivotal for promoting and sustaining Th2 immunity. <italic toggle="yes">In vitro</italic>, activated B cells from HDM-exposed mice presented antigen to T cell receptor transgenic mice (1-DER) T cells and induced a Th2 phenotype. <italic toggle="yes">In vivo</italic>, B cell contribution to the induction of Th2 inflammation and asthmatic features have been shown to be dependent on HDM allergen dose and on the tissue site at which Th2 cytokine is probed. Only under low dose of allergens, B cells become necessary for optimal expansion of HDM-reactive Th2, central memory T (T<sub>CM</sub>) cells, and for development of eosinophilic airway inflammation and bronchial hyperreactivity (<xref rid="B152" ref-type="bibr">152</xref>). Therefore, HDM proteases target different substrates that are required in various immune mechanisms starting from epithelial barrier function, proceeding to innate inflammatory responses, involving T cell polarization, and even have a direct effect on IgE production by B cells.</p></sec><sec id="s6"><title>Therapeutic Approaches to HDM-Induced Allergy</title><p>HDM avoidance is the first recommended method to reduce the symptoms in clinic now. However, in Cochrane meta-analyses on mite avoidance, the use of environmental control measures was found to be of little benefit in reducing rhinitis symptoms, and with no effect on alleviating asthma symptoms (<xref rid="B153" ref-type="bibr">153</xref>, <xref rid="B154" ref-type="bibr">154</xref>). In addition to allergen avoidance, pharmacotherapy is also part of the treatment. These therapeutic approaches primarily aimed at controlling inflammation of the upper and lower airways employ antihistamines, leukotriene receptor antagonist, and/or inhaled/intranasal corticosteroids (<xref rid="B155" ref-type="bibr">155</xref>). Although these phamacological treatments are effective and safe in most cases, they rarely change the course of HDM-related allergic diseases.</p><p>Allergen immunotherapy (AIT) consists of administration of small doses of allergen. This therapeutic approach has been used for the past century as subcutaneous immunotherapy (SCIT), and more recently as sublingual immunotherapy (SLIT). In contrast with pharmacotherapy, effective AIT activates multiple mechanisms. Firstly, SCIT reduces allergen specific IgE production and increases the production of specific IgG (which acts as a &#8220;blocking&#8221; antibody) (<xref rid="B156" ref-type="bibr">156</xref>). Secondly, AIT induces a major change in allergen-specific T-cell subsets, including immunologic deviation (stimulation of Th0/Th1 lymphocytes, with increased IFN-&#947; and IL-2 production), specific T-lymphocyte anergy (a decrease in Th2/Th0 lymphocyte counts), and induction of regulatory T-lymphocytes, which produce cytokines such as IL-10 and TGF-&#946;. Thirdly, suppression of peripheral ILCs, especially ILC2s, might contribute to Th2 suppression and immunologic tolerance (<xref rid="B157" ref-type="bibr">157</xref>). Lastly, AIT decreases inflammatory cell recruitment, activation, and the release of mediators including histamine, prostaglandin D2, and eosinophil cationic protein (<xref rid="B158" ref-type="bibr">158</xref>). All these effects of AIT contribute to immune tolerance and long-lasting changes in the immune system, even after the treatment is discontinued. The mechanisms of SLIT are not fully understood but they seem to be similar to those of SCIT, except that in SLIT, mucosal dendritic cells are particularly involved in this process (<xref rid="B159" ref-type="bibr">159</xref>). A prolonged duration of treatment is required for long-term efficacy after discontinuation of immunotherapy (<xref rid="B160" ref-type="bibr">160</xref>). AIT was previously shown to prevent the development of new sensitizations in HDM monosensitized children (<xref rid="B161" ref-type="bibr">161</xref>). The European Academy of Allergy and Clinical Immunology (EAACI) guidelines on AIT for allergic asthma and the new Global Initiative for Asthma (GINA) guidelines now include HDM SCIT (<xref rid="B162" ref-type="bibr">162</xref>). It is also worth noting that recent SLIT-based AIT trials in house dust mite (HDM) allergic asthma have shown some efficacy. Thus, sublingual HDM tablet AIT were found to reduce asthma exacerbations and enabled steroid reduction. Accordingly, the new GINA 2020 guidelines recommend SLIT therapy for HDM-related allergic asthma for individuals with mild asthma (FEV1 &gt; 70%) (<xref rid="B163" ref-type="bibr">163</xref>). The selection of allergen components, total number of allergens, and relative proportions of individual allergen components included in therapeutic mixtures are critical aspects of formulating allergen immunotherapy. When preparing mixtures of allergen extracts, the prescribing physician must take into account the cross-reactivity of allergen extracts and the potential for allergen degradation caused by proteolytic enzymes (<xref rid="B164" ref-type="bibr">164</xref>). AIT has been defined by a WHO leading paperas as &#8220;the only form of treatment able to modify the natural course of allergic diseases&#8221; (<xref rid="B165" ref-type="bibr">165</xref>), and it is the only potential disease-modifying treatment of HDM allergic subjects. Both SCIT and SLIT with HDM vaccine show safety and efficacy in reducing symptoms and medication usage, and in improving quality of life for treatment.</p><p>The clinical significance of group 1 HDM allergens and their serodominance as allergens as well as their activities in priming the innate immune system make them as an attractive target for therapeutic intervention. Resolving the structure of allergens and their earlier molecular interactions with immunological sentinels will pave the way for designing novel therapy used in the future prevention and treatment of asthma.</p></sec><sec id="s7"><title>Conclusions And Perspectives</title><p>The interactions between allergens, immune responses, and airway diseases are highly complex and still incompletely understood. Studies during the last decade were instrumental in casting the light on the role of HDM in allergy and atopy, in general. More specifically, they educated us about the allergenicity of HDM, its structural components, its proteases and its interaction with the innate and the adaptive immune systems. However, HDM extracts used in experimental studies are man-made and often intra-nasally administered in large volumes of solution. Thus, they may vary from HDM in the environment by their allergen composition and the presence of other environmental substances. In this regard, the allergenicity of dust mites is not solely dependent on the structural components of independent mite proteins such as Der p 1 since biological fluids and proteins in general block its proteolytic activity and therefore, its allergic sensitization potential. In fact, group 1 allergens from HDM are digestive enzymes excreted in fecal pellets which are inhalable by humans. The accumulation of these microscopic fecal pellets on the airway surface achieves a high localized concentration of the enzyme and reduces their resistance to proteolytic inactivation (<xref rid="B37" ref-type="bibr">37</xref>).</p><p>New advancements resulted in a paradigm shift in the field of asthma and it is increasingly appreciated that in addition to IgE, asthma is mediated by complex responses orchestrated via extensive crosstalk between the epithelium, professional APCs and cells of the adaptive immunity. These interactions are mediated via environmental allergen exposure and can be influenced by several factors including genetic predisposition, polymorphism, and the status of epithelial cell integrity or viral exposure. Dissecting the role of HDM allergens has helped in understanding the role of innate immunity and shed the light on its relevance in initiating and perpetuating the lung inflammation. Given the large number of HDM allergens and apart from group 1, 2, 3, and 9, our knowledge is still lacking regarding mechanisms utilized by allergens to trigger the immune system. Characterization of the molecular basis of allergenicity and the functional bioactivities of these allergens will pave the way for identification of novel therapeutics (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B166" ref-type="bibr">166</xref>). Furthermore, successful drug design would selectively target various aspects of HDM-epithelial cell interactions, which could potentially inhibit the driving signal for activating the innate system that is required to sustain adaptive immunity. Drugs that inhibit the release of epithelial cell derived cytokines would inhibit HDM-induced allergic sensitization.</p></sec><sec id="s8"><title>Author Contributions</title><p>AA, AOA, and PB: planned the manuscript. AA, EK, MJ, and PB: wrote the manuscript. AOA and PB: edited the manuscript. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="COI-statement" id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by NIH grants AI145144, AI18958, and DK101323 (to PB); and The Ohio State University Center for Clinical and Translational Science Longitudinal Pilot Award (CCTS) and NIH grants R21 AI113477, R01 AI24121, and R01 HL127651 (to AOA). AA was supported by Taawon Welfare Association, West Bank, Palestine and Bank of Palestine.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellwood</surname><given-names>P</given-names></name><name name-style="western"><surname>Asher</surname><given-names>MI</given-names></name><name name-style="western"><surname>Billo</surname><given-names>NE</given-names></name><name name-style="western"><surname>Bissell</surname><given-names>K</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Ellwood</surname><given-names>EM</given-names></name><etal/></person-group>. <article-title>The Global Asthma Network rationale and methods for phase I global surveillance: prevalence, severity, management and risk factors</article-title>. <source>Eur Respir J.</source> (<year>2017</year>) <volume>49</volume>:<fpage>1601605</fpage>. <pub-id pub-id-type="doi">10.1183/13993003.01605-2016</pub-id><pub-id pub-id-type="pmid">28077477</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dharmage</surname><given-names>SC</given-names></name><name name-style="western"><surname>Perret</surname><given-names>JL</given-names></name><name name-style="western"><surname>Custovic</surname><given-names>A</given-names></name></person-group>. <article-title>Epidemiology of asthma in children and adults</article-title>. <source>Front Pediatr.</source> (<year>2019</year>) <volume>7</volume>:<fpage>246</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2019.00246</pub-id><pub-id pub-id-type="pmid">31275909</pub-id><pub-id pub-id-type="pmcid">PMC6591438</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Platts-Mills</surname><given-names>TA</given-names></name><name name-style="western"><surname>Chapman</surname><given-names>MD</given-names></name></person-group>. <article-title>Dust mites: immunology, allergic disease, and environmental control</article-title>. <source>J Allergy Clin Immunol.</source> (<year>1987</year>) <volume>80</volume>:<fpage>755</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-6749(87)80261-0</pub-id><pub-id pub-id-type="pmid">3320157</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arlian</surname><given-names>LG</given-names></name><name name-style="western"><surname>Platts-Mills</surname><given-names>TA</given-names></name></person-group>. <article-title>The biology of dust mites and the remediation of mite allergens in allergic disease</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2001</year>) <volume>107</volume>(<issue>Suppl. 3</issue>):<fpage>S406</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1067/mai.2001.113670</pub-id><pub-id pub-id-type="pmid">11242601</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>WR</given-names></name></person-group>. <article-title>House dust allergy and immunotherapy</article-title>. <source>Hum Vaccin Immunother.</source> (<year>2012</year>) <volume>8</volume>:<fpage>1469</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.4161/hv.20812</pub-id><pub-id pub-id-type="pmid">22894952</pub-id><pub-id pub-id-type="pmcid">PMC3660285</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanchez-Borges</surname><given-names>M</given-names></name><name name-style="western"><surname>Fernandez-Caldas</surname><given-names>E</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>WR</given-names></name><name name-style="western"><surname>Chapman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Lee</surname><given-names>BW</given-names></name><name name-style="western"><surname>Caraballo</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem</article-title>. <source>World Allergy Organ J.</source> (<year>2017</year>) <volume>10</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/s40413-017-0145-4</pub-id><pub-id pub-id-type="pmid">28451053</pub-id><pub-id pub-id-type="pmcid">PMC5394630</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calderon</surname><given-names>MA</given-names></name><name name-style="western"><surname>Linneberg</surname><given-names>A</given-names></name><name name-style="western"><surname>Kleine-Tebbe</surname><given-names>J</given-names></name><name name-style="western"><surname>De Blay</surname><given-names>F</given-names></name><name name-style="western"><surname>Hernandez Fernandez de Rojas</surname><given-names>D</given-names></name><name name-style="western"><surname>Virchow</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>Respiratory allergy caused by house dust mites: What do we really know?</article-title><source>J Allergy Clin Immunol.</source> (<year>2015</year>) <volume>136</volume>:<fpage>38</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2014.10.012</pub-id><pub-id pub-id-type="pmid">25457152</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gregory</surname><given-names>LG</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>CM</given-names></name></person-group>. <article-title>Orchestrating house dust mite-associated allergy in the lung</article-title>. <source>Trends Immunol.</source> (<year>2011</year>) <volume>32</volume>:<fpage>402</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2011.06.006</pub-id><pub-id pub-id-type="pmid">21783420</pub-id><pub-id pub-id-type="pmcid">PMC3381841</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Alba</surname><given-names>J</given-names></name><name name-style="western"><surname>Raemdonck</surname><given-names>K</given-names></name><name name-style="western"><surname>Dekkak</surname><given-names>A</given-names></name><name name-style="western"><surname>Collins</surname><given-names>M</given-names></name><name name-style="western"><surname>Wong</surname><given-names>S</given-names></name><name name-style="western"><surname>Nials</surname><given-names>AT</given-names></name><etal/></person-group>. <article-title>House dust mite induces direct airway inflammation <italic toggle="yes">in vivo</italic>: implications for future disease therapy?</article-title><source>Eur Respir J.</source> (<year>2010</year>) <volume>35</volume>:<fpage>1377</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00022908</pub-id><pub-id pub-id-type="pmid">19840954</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Birrell</surname><given-names>MA</given-names></name><name name-style="western"><surname>Van Oosterhout</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Belvisi</surname><given-names>MG</given-names></name></person-group>. <article-title>Do the current house dust mite-driven models really mimic allergic asthma?</article-title><source>Eur Respir J.</source> (<year>2010</year>) <volume>36</volume>:<fpage>1220</fpage>&#8211;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00069110</pub-id><pub-id pub-id-type="pmid">21037376</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soto-Quiros</surname><given-names>M</given-names></name><name name-style="western"><surname>Avila</surname><given-names>L</given-names></name><name name-style="western"><surname>Platts-Mills</surname><given-names>TA</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>JF</given-names></name><name name-style="western"><surname>Erdman</surname><given-names>DD</given-names></name><name name-style="western"><surname>Carper</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2012</year>) <volume>129</volume>:<fpage>1499</fpage>&#8211;<lpage>505</lpage>.e5. <pub-id pub-id-type="doi">10.1016/j.jaci.2012.03.040</pub-id><pub-id pub-id-type="pmid">22560151</pub-id><pub-id pub-id-type="pmcid">PMC3792652</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>CS</given-names></name><name name-style="western"><surname>Poletti</surname><given-names>G</given-names></name><name name-style="western"><surname>Kebadze</surname><given-names>T</given-names></name><name name-style="western"><surname>Morris</surname><given-names>J</given-names></name><name name-style="western"><surname>Woodcock</surname><given-names>A</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>SL</given-names></name><etal/></person-group>. <article-title>Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children</article-title>. <source>Thorax.</source> (<year>2006</year>) <volume>61</volume>:<fpage>376</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1136/thx.2005.042523</pub-id><pub-id pub-id-type="pmid">16384881</pub-id><pub-id pub-id-type="pmcid">PMC2111190</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Green</surname><given-names>RM</given-names></name><name name-style="western"><surname>Custovic</surname><given-names>A</given-names></name><name name-style="western"><surname>Sanderson</surname><given-names>G</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>J</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>SL</given-names></name><name name-style="western"><surname>Woodcock</surname><given-names>A</given-names></name></person-group>. <article-title>Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study</article-title>. <source>BMJ.</source> (<year>2002</year>) <volume>324</volume>:<fpage>763</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.324.7340.763</pub-id><pub-id pub-id-type="pmid">11923159</pub-id><pub-id pub-id-type="pmcid">PMC100316</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trian</surname><given-names>T</given-names></name><name name-style="western"><surname>Allard</surname><given-names>B</given-names></name><name name-style="western"><surname>Dupin</surname><given-names>I</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>G</given-names></name><name name-style="western"><surname>Ousova</surname><given-names>O</given-names></name><name name-style="western"><surname>Maurat</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>House dust mites induce proliferation of severe asthmatic smooth muscle cells via an epithelium-dependent pathway</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>2015</year>) <volume>191</volume>:<fpage>538</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201409-1582OC</pub-id><pub-id pub-id-type="pmid">25569771</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mouthuy</surname><given-names>J</given-names></name><name name-style="western"><surname>Detry</surname><given-names>B</given-names></name><name name-style="western"><surname>Sohy</surname><given-names>C</given-names></name><name name-style="western"><surname>Pirson</surname><given-names>F</given-names></name><name name-style="western"><surname>Pilette</surname><given-names>C</given-names></name></person-group>. <article-title>Presence in sputum of functional dust mite-specific IgE antibodies in intrinsic asthma</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>2011</year>) <volume>184</volume>:<fpage>206</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201009-1434OC</pub-id><pub-id pub-id-type="pmid">21474647</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bordas-Le Floch</surname><given-names>V</given-names></name><name name-style="western"><surname>Le Mignon</surname><given-names>M</given-names></name><name name-style="western"><surname>Bussieres</surname><given-names>L</given-names></name><name name-style="western"><surname>Jain</surname><given-names>K</given-names></name><name name-style="western"><surname>Martelet</surname><given-names>A</given-names></name><name name-style="western"><surname>Baron-Bodo</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>A combined transcriptome and proteome analysis extends the allergome of house dust mite Dermatophagoides species</article-title>. <source>PLoS ONE.</source> (<year>2017</year>) <volume>12</volume>:<fpage>e0185830</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0185830</pub-id><pub-id pub-id-type="pmid">28982170</pub-id><pub-id pub-id-type="pmcid">PMC5628879</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>WR</given-names></name><name name-style="western"><surname>Hales</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Smith</surname><given-names>WA</given-names></name></person-group><article-title>House dust mite allergens in asthma and allergy</article-title>. <source>Trends Mol Med.</source> (<year>2010</year>) <volume>16</volume>:<fpage>321</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2010.04.008</pub-id><pub-id pub-id-type="pmid">20605742</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chapman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Pomes</surname><given-names>A</given-names></name><name name-style="western"><surname>Breiteneder</surname><given-names>H</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>F</given-names></name></person-group>. <article-title>Nomenclature and structural biology of allergens</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2007</year>) <volume>119</volume>:<fpage>414</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2006.11.001</pub-id><pub-id pub-id-type="pmid">17166572</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chapman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Platts-Mills</surname><given-names>TA</given-names></name></person-group>. <article-title>Purification and characterization of the major allergen from <italic toggle="yes">Dermatophagoides pteronyssinus</italic>-antigen P1</article-title>. <source>J Immunol.</source> (<year>1980</year>) <volume>125</volume>:<fpage>587</fpage>&#8211;<lpage>92</lpage>.<pub-id pub-id-type="pmid">6771329</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trompette</surname><given-names>A</given-names></name><name name-style="western"><surname>Divanovic</surname><given-names>S</given-names></name><name name-style="western"><surname>Visintin</surname><given-names>A</given-names></name><name name-style="western"><surname>Blanchard</surname><given-names>C</given-names></name><name name-style="western"><surname>Hegde</surname><given-names>RS</given-names></name><name name-style="western"><surname>Madan</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein</article-title>. <source>Nature.</source> (<year>2009</year>) <volume>457</volume>:<fpage>585</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nature07548</pub-id><pub-id pub-id-type="pmid">19060881</pub-id><pub-id pub-id-type="pmcid">PMC2843411</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>C</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>S</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>GA</given-names></name></person-group>. <article-title>Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium</article-title>. <source>J Immunol.</source> (<year>1998</year>) <volume>161</volume>:<fpage>3645</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">9759888</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ando</surname><given-names>T</given-names></name><name name-style="western"><surname>Homma</surname><given-names>R</given-names></name><name name-style="western"><surname>Ino</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ito</surname><given-names>G</given-names></name><name name-style="western"><surname>Miyahara</surname><given-names>A</given-names></name><name name-style="western"><surname>Yanagihara</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Trypsin-like protease of mites: purification and characterization of trypsin-like protease from mite faecal extract <italic toggle="yes">Dermatophagoides farinae</italic>. Relationship between trypsin-like protease and Der f III</article-title>. <source>Clin Exper Allergy</source>. (<year>1993</year>) <volume>23</volume>:<fpage>777</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2222.1993.tb00366.x</pub-id><pub-id pub-id-type="pmid">10779309</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bennett</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>WR</given-names></name></person-group>. <article-title>Cloning and sequencing of the group 6 allergen of <italic toggle="yes">Dermatophagoides pteronyssinus</italic></article-title>. <source>Clin Exper Allergy</source>. (<year>1996</year>) <volume>26</volume>:<fpage>1150</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2222.1996.tb00501.x</pub-id><pub-id pub-id-type="pmid">8911700</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name><name name-style="western"><surname>Weber</surname><given-names>M</given-names></name><name name-style="western"><surname>Blatt</surname><given-names>K</given-names></name><name name-style="western"><surname>Swoboda</surname><given-names>I</given-names></name><name name-style="western"><surname>Focke-Tejkl</surname><given-names>M</given-names></name><name name-style="western"><surname>Valent</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine</article-title>. <source>J Immunol.</source> (<year>2014</year>) <volume>192</volume>:<fpage>4867</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1400064</pub-id><pub-id pub-id-type="pmid">24733847</pub-id><pub-id pub-id-type="pmcid">PMC4582415</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weghofer</surname><given-names>M</given-names></name><name name-style="western"><surname>Grote</surname><given-names>M</given-names></name><name name-style="western"><surname>Resch</surname><given-names>Y</given-names></name><name name-style="western"><surname>Casset</surname><given-names>A</given-names></name><name name-style="western"><surname>Kneidinger</surname><given-names>M</given-names></name><name name-style="western"><surname>Kopec</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Identification of Der p 23, a peritrophin-like protein, as a new major <italic toggle="yes">Dermatophagoides pteronyssinus</italic> allergen associated with the peritrophic matrix of mite fecal pellets</article-title>. <source>J Immunol.</source> (<year>2013</year>) <volume>190</volume>:<fpage>3059</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1202288</pub-id><pub-id pub-id-type="pmid">23460742</pub-id><pub-id pub-id-type="pmcid">PMC4582595</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mueller</surname><given-names>GA</given-names></name><name name-style="western"><surname>Randall</surname><given-names>TA</given-names></name><name name-style="western"><surname>Glesner</surname><given-names>J</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>LC</given-names></name><name name-style="western"><surname>Perera</surname><given-names>L</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>LL</given-names></name><etal/></person-group>. <article-title>Serological, genomic and structural analyses of the major mite allergen Der p 23</article-title>. <source>Clin Exper Allergy.</source> (<year>2016</year>) <volume>46</volume>:<fpage>365</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1111/cea.12680</pub-id><pub-id pub-id-type="pmid">26602749</pub-id><pub-id pub-id-type="pmcid">PMC4732897</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matos Semedo</surname><given-names>F</given-names></name><name name-style="western"><surname>Dorofeeva</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pires</surname><given-names>AP</given-names></name><name name-style="western"><surname>Tomaz</surname><given-names>E</given-names></name><name name-style="western"><surname>Taborda Barata</surname><given-names>L</given-names></name><name name-style="western"><surname>Inacio</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Der p 23: clinical relevance of molecular monosensitization in house dust mite allergy</article-title>. <source>J Investig Allergol Clin Immunol.</source> (<year>2019</year>) <volume>29</volume>:<fpage>314</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.18176/jiaci.0392</pub-id><pub-id pub-id-type="pmid">30957762</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>WR</given-names></name></person-group>. <article-title>Hierarchy and molecular properties of house dust mite allergens</article-title>. <source>Allergol Int.</source> (<year>2015</year>) <volume>64</volume>:<fpage>304</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.alit.2015.05.004</pub-id><pub-id pub-id-type="pmid">26433526</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jimenez-Feijoo</surname><given-names>R</given-names></name><name name-style="western"><surname>Pascal</surname><given-names>M</given-names></name><name name-style="western"><surname>Moya</surname><given-names>R</given-names></name><name name-style="western"><surname>Riggioni</surname><given-names>C</given-names></name><name name-style="western"><surname>Dominguez</surname><given-names>O</given-names></name><name name-style="western"><surname>Lozano</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Molecular diagnosis in house dust mite-allergic patients suggests that Der p 23 is clinically relevant in asthmatic children</article-title>. <source>J Investig Allergol Clin Immunol.</source> (<year>2020</year>) <volume>30</volume>:<fpage>127</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.18176/jiaci.0431</pub-id><pub-id pub-id-type="pmid">31283524</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>JM</given-names></name><name name-style="western"><surname>Platts-Mills</surname><given-names>TAE</given-names></name></person-group>. <article-title>Home environmental interventions for house dust mite</article-title>. <source>J Allergy Clin Immunol Pract.</source> (<year>2018</year>) <volume>6</volume>:<fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaip.2017.10.003</pub-id><pub-id pub-id-type="pmid">29310755</pub-id><pub-id pub-id-type="pmcid">PMC6474366</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacquet</surname><given-names>A</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>C</given-names></name></person-group>. <article-title>Proteolytic, lipidergic and polysaccharide molecular recognition shape innate responses to house dust mite allergens</article-title>. <source>Allergy.</source> (<year>2020</year>) <volume>75</volume>:<fpage>33</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1111/all.13940</pub-id><pub-id pub-id-type="pmid">31166610</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Georas</surname><given-names>SN</given-names></name><name name-style="western"><surname>Rezaee</surname><given-names>F</given-names></name></person-group>. <article-title>Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2014</year>) <volume>134</volume>:<fpage>509</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2014.05.049</pub-id><pub-id pub-id-type="pmid">25085341</pub-id><pub-id pub-id-type="pmcid">PMC4170838</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sweerus</surname><given-names>K</given-names></name><name name-style="western"><surname>Lachowicz-Scroggins</surname><given-names>M</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>E</given-names></name><name name-style="western"><surname>LaFemina</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Parikh</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2017</year>) <volume>139</volume>:<fpage>72</fpage>&#8211;<lpage>81</lpage>.e1. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.02.035</pub-id><pub-id pub-id-type="pmid">27215490</pub-id><pub-id pub-id-type="pmcid">PMC5073041</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Newton</surname><given-names>GK</given-names></name><name name-style="western"><surname>Perrior</surname><given-names>TR</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>C</given-names></name></person-group>. <article-title>Allergen delivery inhibitors: a rationale for targeting sentinel innate immune signaling of group 1 house dust mite allergens through structure-based protease inhibitor design</article-title>. <source>Mol Pharmacol.</source> (<year>2018</year>) <volume>94</volume>:<fpage>1007</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1124/mol.118.112730</pub-id><pub-id pub-id-type="pmid">29976563</pub-id><pub-id pub-id-type="pmcid">PMC6064784</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>H</given-names></name><name name-style="western"><surname>Winton</surname><given-names>HL</given-names></name><name name-style="western"><surname>Soeller</surname><given-names>C</given-names></name><name name-style="western"><surname>Gruenert</surname><given-names>DC</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Cannell</surname><given-names>MB</given-names></name><etal/></person-group>. <article-title>Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite allergen Der p 1</article-title>. <source>Clin Exper Allergy.</source> (<year>2000</year>) <volume>30</volume>:<fpage>685</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2222.2000.00820.x</pub-id><pub-id pub-id-type="pmid">10792361</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>H</given-names></name><name name-style="western"><surname>Winton</surname><given-names>HL</given-names></name><name name-style="western"><surname>Soeller</surname><given-names>C</given-names></name><name name-style="western"><surname>Tovey</surname><given-names>ER</given-names></name><name name-style="western"><surname>Gruenert</surname><given-names>DC</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions</article-title>. <source>J Clin Investig.</source> (<year>1999</year>) <volume>104</volume>:<fpage>123</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1172/JCI5844</pub-id><pub-id pub-id-type="pmid">10393706</pub-id><pub-id pub-id-type="pmcid">PMC408401</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>J</given-names></name><name name-style="western"><surname>Newton</surname><given-names>GK</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>MR</given-names></name><name name-style="western"><surname>Perrior</surname><given-names>TR</given-names></name><etal/></person-group>. <article-title>Allergen delivery inhibitors: characterisation of potent and selective inhibitors of Der p 1 and their attenuation of airway responses to house dust mite allergens</article-title>. <source>Int J Mol Sci.</source> (<year>2018</year>) <volume>19</volume>: <fpage>3166</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19103166</pub-id><pub-id pub-id-type="pmid">30326568</pub-id><pub-id pub-id-type="pmcid">PMC6214017</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roche</surname><given-names>N</given-names></name><name name-style="western"><surname>Chinet</surname><given-names>TC</given-names></name><name name-style="western"><surname>Belouchi</surname><given-names>NE</given-names></name><name name-style="western"><surname>Julie</surname><given-names>C</given-names></name><name name-style="western"><surname>Huchon</surname><given-names>GJ</given-names></name></person-group>. <article-title><italic toggle="yes">Dermatophagoides pteronyssinus</italic> and bioelectric properties of airway epithelium: role of cysteine proteases</article-title>. <source>Eur Respir J.</source> (<year>2000</year>) <volume>16</volume>:<fpage>309</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-3003.2000.16b20.x</pub-id><pub-id pub-id-type="pmid">10968508</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reithofer</surname><given-names>M</given-names></name><name name-style="western"><surname>Jahn-Schmid</surname><given-names>B</given-names></name></person-group>. <article-title>Allergens with protease activity from house dust mites</article-title>. <source>Int J Mol Sci.</source> (<year>2017</year>) <volume>18</volume>:<fpage>1368</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18071368</pub-id><pub-id pub-id-type="pmid">28653989</pub-id><pub-id pub-id-type="pmcid">PMC5535861</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>H</given-names></name><name name-style="western"><surname>Winton</surname><given-names>HL</given-names></name><name name-style="western"><surname>Soeller</surname><given-names>C</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>GW</given-names></name><name name-style="western"><surname>Gruenert</surname><given-names>DC</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of <italic toggle="yes">Dermatophagoides pteronyssinus</italic></article-title>. <source>Clin Exper Allergy</source>. (<year>2001</year>) <volume>31</volume>:<fpage>279</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2222.2001.00970.x</pub-id><pub-id pub-id-type="pmid">11251630</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winton</surname><given-names>HL</given-names></name><name name-style="western"><surname>Wan</surname><given-names>H</given-names></name><name name-style="western"><surname>Cannell</surname><given-names>MB</given-names></name><name name-style="western"><surname>Gruenert</surname><given-names>DC</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Garrod</surname><given-names>DR</given-names></name><etal/></person-group>. <article-title>Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability</article-title>. <source>Clin Exp Allergy.</source> (<year>1998</year>) <volume>28</volume>:<fpage>1273</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2222.1998.00354.x</pub-id><pub-id pub-id-type="pmid">9824395</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Mangat</surname><given-names>SC</given-names></name><name name-style="western"><surname>Perera Baruhupolage</surname><given-names>C</given-names></name><name name-style="western"><surname>Garrod</surname><given-names>DR</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>C</given-names></name></person-group>. <article-title>Pathways of airway oxidant formation by house dust mite allergens and viral RNA converge through myosin motors, pannexons and Toll-like receptor 4</article-title>. <source>Immunity Inflam Dis.</source> (<year>2018</year>) <volume>6</volume>:<fpage>276</fpage>&#8211;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1002/iid3.216</pub-id><pub-id pub-id-type="pmid">29542272</pub-id><pub-id pub-id-type="pmcid">PMC5946151</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>A</given-names></name><name name-style="western"><surname>Farmer</surname><given-names>K</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>L</given-names></name><name name-style="western"><surname>Kalsheker</surname><given-names>N</given-names></name><name name-style="western"><surname>Pritchard</surname><given-names>D</given-names></name><name name-style="western"><surname>Haslett</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>House dust mite Der p 1 downregulates defenses of the lung by inactivating elastase inhibitors</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>2003</year>) <volume>29</volume>(<issue>3 Pt 1</issue>):<fpage>381</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2003-0060OC</pub-id><pub-id pub-id-type="pmid">12689923</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalsheker</surname><given-names>NA</given-names></name><name name-style="western"><surname>Deam</surname><given-names>S</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>L</given-names></name><name name-style="western"><surname>Sreedharan</surname><given-names>S</given-names></name><name name-style="western"><surname>Brocklehurst</surname><given-names>K</given-names></name><name name-style="western"><surname>Lomas</surname><given-names>DA</given-names></name></person-group>. <article-title>The house dust mite allergen Der p1 catalytically inactivates alpha 1-antitrypsin by specific reactive centre loop cleavage: a mechanism that promotes airway inflammation and asthma</article-title>. <source>Biochem Biophys Res Commun.</source> (<year>1996</year>) <volume>221</volume>:<fpage>59</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1996.0544</pub-id><pub-id pub-id-type="pmid">8660343</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gough</surname><given-names>L</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>HF</given-names></name><name name-style="western"><surname>Shakib</surname><given-names>F</given-names></name></person-group>. <article-title>The proteolytic activity of the major dust mite allergen Der p 1 enhances the IgE antibody response to a bystander antigen</article-title>. <source>Clin Exper Allergy.</source> (<year>2001</year>) <volume>31</volume>:<fpage>1594</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2222.2001.01207.x</pub-id><pub-id pub-id-type="pmid">11678860</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gough</surname><given-names>L</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>E</given-names></name><name name-style="western"><surname>Bayley</surname><given-names>D</given-names></name><name name-style="western"><surname>Van Heeke</surname><given-names>G</given-names></name><name name-style="western"><surname>Shakib</surname><given-names>F</given-names></name></person-group>. <article-title>Proteolytic activity of the house dust mite allergen Der p 1 enhances allergenicity in a mouse inhalation model</article-title>. <source>Clin Exper Allergy.</source> (<year>2003</year>) <volume>33</volume>:<fpage>1159</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2222.2003.01716.x</pub-id><pub-id pub-id-type="pmid">12911793</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henriquez</surname><given-names>OA</given-names></name><name name-style="western"><surname>Den Beste</surname><given-names>K</given-names></name><name name-style="western"><surname>Hoddeson</surname><given-names>EK</given-names></name><name name-style="western"><surname>Parkos</surname><given-names>CA</given-names></name><name name-style="western"><surname>Nusrat</surname><given-names>A</given-names></name><name name-style="western"><surname>Wise</surname><given-names>SK</given-names></name></person-group>. <article-title>House dust mite allergen Der p 1 effects on sinonasal epithelial tight junctions</article-title>. <source>Int Forum Allergy Rhinol.</source> (<year>2013</year>) <volume>3</volume>:<fpage>630</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/alr.21168</pub-id><pub-id pub-id-type="pmid">23592402</pub-id><pub-id pub-id-type="pmcid">PMC3782710</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewitt</surname><given-names>CR</given-names></name><name name-style="western"><surname>Brown</surname><given-names>AP</given-names></name><name name-style="western"><surname>Hart</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Pritchard</surname><given-names>DI</given-names></name></person-group>. <article-title>A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases</article-title>. <source>J Exp Med.</source> (<year>1995</year>) <volume>182</volume>:<fpage>1537</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1084/jem.182.5.1537</pub-id><pub-id pub-id-type="pmid">7595223</pub-id><pub-id pub-id-type="pmcid">PMC2192194</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shakib</surname><given-names>F</given-names></name><name name-style="western"><surname>Ghaemmaghami</surname><given-names>AM</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>HF</given-names></name></person-group><article-title>The molecular basis of allergenicity</article-title>. <source>Trends Immunol.</source> (<year>2008</year>) <volume>29</volume>:<fpage>633</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2008.08.007</pub-id><pub-id pub-id-type="pmid">18951844</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wildenberg</surname><given-names>ME</given-names></name><name name-style="western"><surname>van den Brink</surname><given-names>GR</given-names></name></person-group>. <article-title>House dust mite: a new player in intestinal inflammation?</article-title><source>Gut.</source> (<year>2016</year>) <volume>65</volume>:<fpage>727</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2015-311042</pub-id><pub-id pub-id-type="pmid">26762194</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tulic</surname><given-names>MK</given-names></name><name name-style="western"><surname>Vivinus-Nebot</surname><given-names>M</given-names></name><name name-style="western"><surname>Rekima</surname><given-names>A</given-names></name><name name-style="western"><surname>Rabelo Medeiros</surname><given-names>S</given-names></name><name name-style="western"><surname>Bonnart</surname><given-names>C</given-names></name><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Presence of commensal house dust mite allergen in human gastrointestinal tract: a potential contributor to intestinal barrier dysfunction</article-title>. <source>Gut.</source> (<year>2016</year>) <volume>65</volume>:<fpage>757</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2015-310523</pub-id><pub-id pub-id-type="pmid">26646935</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willart</surname><given-names>MA</given-names></name><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name></person-group>. <article-title>The danger within: endogenous danger signals, atopy and asthma</article-title>. <source>Clin Exper Allergy.</source> (<year>2009</year>) <volume>39</volume>:<fpage>12</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2222.2008.03118.x</pub-id><pub-id pub-id-type="pmid">19016800</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proud</surname><given-names>D</given-names></name><name name-style="western"><surname>Leigh</surname><given-names>R</given-names></name></person-group>. <article-title>Epithelial cells and airway diseases</article-title>. <source>Immunol Rev.</source> (<year>2011</year>) <volume>242</volume>:<fpage>186</fpage>&#8211;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01033.x</pub-id><pub-id pub-id-type="pmid">21682746</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H</given-names></name></person-group>. <article-title>The airway epithelium in asthma</article-title>. <source>Nat Med.</source> (<year>2012</year>) <volume>18</volume>:<fpage>684</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2737</pub-id><pub-id pub-id-type="pmid">22561832</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spits</surname><given-names>H</given-names></name><name name-style="western"><surname>Cupedo</surname><given-names>T</given-names></name></person-group>. <article-title>Innate lymphoid cells: emerging insights in development, lineage relationships, and function</article-title>. <source>Ann Rev Immunol.</source> (<year>2012</year>) <volume>30</volume>:<fpage>647</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075053</pub-id><pub-id pub-id-type="pmid">22224763</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grunstein</surname><given-names>MM</given-names></name><name name-style="western"><surname>Veler</surname><given-names>H</given-names></name><name name-style="western"><surname>Shan</surname><given-names>X</given-names></name><name name-style="western"><surname>Larson</surname><given-names>J</given-names></name><name name-style="western"><surname>Grunstein</surname><given-names>JS</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>S</given-names></name></person-group>. <article-title>Proasthmatic effects and mechanisms of action of the dust mite allergen, Der p 1, in airway smooth muscle</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2005</year>) <volume>116</volume>:<fpage>94</fpage>&#8211;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2005.03.046</pub-id><pub-id pub-id-type="pmid">15990780</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Allen-Philbey</surname><given-names>K</given-names></name><name name-style="western"><surname>Perera Baruhupolage</surname><given-names>C</given-names></name><name name-style="western"><surname>Tachie-Menson</surname><given-names>T</given-names></name><name name-style="western"><surname>Mangat</surname><given-names>SC</given-names></name><etal/></person-group>. <article-title>Innate generation of thrombin and intracellular oxidants in airway epithelium by allergen Der p 1</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2016</year>) <volume>138</volume>:<fpage>1224</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.05.006</pub-id><pub-id pub-id-type="pmid">27345173</pub-id><pub-id pub-id-type="pmcid">PMC5052125</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Tachie-Menson</surname><given-names>T</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>N</given-names></name><name name-style="western"><surname>Garrod</surname><given-names>DR</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>C</given-names></name></person-group>. <article-title>Allergen-dependent oxidant formation requires purinoceptor activation of ADAM 10 and prothrombin</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2017</year>) <volume>139</volume>:<fpage>2023</fpage>&#8211;<lpage>6</lpage>.e9. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.12.954</pub-id><pub-id pub-id-type="pmid">28111309</pub-id><pub-id pub-id-type="pmcid">PMC5457034</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagano</surname><given-names>O</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>D</given-names></name><name name-style="western"><surname>Hartmann</surname><given-names>D</given-names></name><name name-style="western"><surname>De Strooper</surname><given-names>B</given-names></name><name name-style="western"><surname>Saftig</surname><given-names>P</given-names></name><name name-style="western"><surname>Iwatsubo</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation</article-title>. <source>J Cell Biol.</source> (<year>2004</year>) <volume>165</volume>:<fpage>893</fpage>&#8211;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200310024</pub-id><pub-id pub-id-type="pmid">15197174</pub-id><pub-id pub-id-type="pmcid">PMC2172408</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reiss</surname><given-names>K</given-names></name><name name-style="western"><surname>Saftig</surname><given-names>P</given-names></name></person-group>. <article-title>The &#8220;a disintegrin and metalloprotease&#8221; (ADAM) family of sheddases: physiological and cellular functions</article-title>. <source>Sem Cell Develop Biol.</source> (<year>2009</year>) <volume>20</volume>:<fpage>126</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2008.11.002</pub-id><pub-id pub-id-type="pmid">19049889</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terada</surname><given-names>M</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>EA</given-names></name><name name-style="western"><surname>Jarjour</surname><given-names>NN</given-names></name></person-group>. <article-title>Increased thrombin activity after allergen challenge: a potential link to airway remodeling?</article-title><source>Am J Respir Crit Care Med.</source> (<year>2004</year>) <volume>169</volume>:<fpage>373</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200308-1156OC</pub-id><pub-id pub-id-type="pmid">14630620</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>T</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>RP</given-names></name><name name-style="western"><surname>Grimm</surname><given-names>M</given-names></name><name name-style="western"><surname>Durk</surname><given-names>T</given-names></name><name name-style="western"><surname>Cicko</surname><given-names>S</given-names></name><name name-style="western"><surname>Zeiser</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>A potential role for P2X7R in allergic airway inflammation in mice and humans</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>2011</year>) <volume>44</volume>:<fpage>456</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2010-0129OC</pub-id><pub-id pub-id-type="pmid">20508067</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Comhair</surname><given-names>SAA</given-names></name><name name-style="western"><surname>Erzurum</surname><given-names>SC</given-names></name></person-group>. <article-title>Redox control of asthma: molecular mechanisms and therapeutic opportunities</article-title>. <source>Antioxid Redox Sign.</source> (<year>2010</year>) <volume>12</volume>:<fpage>93</fpage>&#8211;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2008.2425</pub-id><pub-id pub-id-type="pmid">19634987</pub-id><pub-id pub-id-type="pmcid">PMC2824520</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cunningham</surname><given-names>PT</given-names></name><name name-style="western"><surname>Elliot</surname><given-names>CE</given-names></name><name name-style="western"><surname>Lenzo</surname><given-names>JC</given-names></name><name name-style="western"><surname>Jarnicki</surname><given-names>AG</given-names></name><name name-style="western"><surname>Larcombe</surname><given-names>AN</given-names></name><name name-style="western"><surname>Zosky</surname><given-names>GR</given-names></name><etal/></person-group>. <article-title>Sensitizing and Th2 adjuvant activity of cysteine protease allergens</article-title>. <source>Int Arch Allergy Imm.</source> (<year>2012</year>) <volume>158</volume>:<fpage>347</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1159/000334280</pub-id><pub-id pub-id-type="pmid">22472801</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>TK</given-names></name><name name-style="western"><surname>Loh</surname><given-names>XY</given-names></name><name name-style="western"><surname>Peh</surname><given-names>HY</given-names></name><name name-style="western"><surname>Tan</surname><given-names>WN</given-names></name><name name-style="western"><surname>Tan</surname><given-names>WS</given-names></name><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>House dust mite-induced asthma causes oxidative damage and DNA double-strand breaks in the lungs</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2016</year>) <volume>138</volume>:<fpage>84</fpage>&#8211;<lpage>96</lpage>.e1. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.02.017</pub-id><pub-id pub-id-type="pmid">27157131</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Rijt</surname><given-names>LS</given-names></name><name name-style="western"><surname>Utsch</surname><given-names>L</given-names></name><name name-style="western"><surname>Lutter</surname><given-names>R</given-names></name><name name-style="western"><surname>van Ree</surname><given-names>R</given-names></name></person-group><article-title>Oxidative stress: promoter of allergic sensitization to protease allergens?</article-title><source>Int J Mol Sci.</source> (<year>2017</year>) <volume>18</volume>:<fpage>1112</fpage><pub-id pub-id-type="doi">10.3390/ijms18061112</pub-id><pub-id pub-id-type="pmcid">PMC5485936</pub-id><pub-id pub-id-type="pmid">28545251</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Idzko</surname><given-names>M</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H</given-names></name><name name-style="western"><surname>van Nimwegen</surname><given-names>M</given-names></name><name name-style="western"><surname>Kool</surname><given-names>M</given-names></name><name name-style="western"><surname>Willart</surname><given-names>MA</given-names></name><name name-style="western"><surname>Muskens</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells</article-title>. <source>Nat Med.</source> (<year>2007</year>) <volume>13</volume>:<fpage>913</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nm1617</pub-id><pub-id pub-id-type="pmid">17632526</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Shamsuddin</surname><given-names>M</given-names></name><name name-style="western"><surname>Sporn</surname><given-names>PH</given-names></name><name name-style="western"><surname>Denenberg</surname><given-names>M</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>J</given-names></name></person-group>. <article-title>Reduced superoxide dismutase in lung cells of patients with asthma</article-title>. <source>Free Radic Biol Med.</source> (<year>1997</year>) <volume>22</volume>:<fpage>1301</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0891-5849(96)00550-3</pub-id><pub-id pub-id-type="pmid">9098106</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spiteri</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bianco</surname><given-names>A</given-names></name><name name-style="western"><surname>Strange</surname><given-names>RC</given-names></name><name name-style="western"><surname>Fryer</surname><given-names>AA</given-names></name></person-group>. <article-title>Polymorphisms at the glutathione S-transferase, GSTP1 locus: a novel mechanism for susceptibility and development of atopic airway inflammation</article-title>. <source>Allergy.</source> (<year>2000</year>) <volume>55</volume>(<issue>Suppl. 61</issue>):<fpage>15</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1034/j.1398-9995.2000.00502.x</pub-id><pub-id pub-id-type="pmid">10919500</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kauffman</surname><given-names>HF</given-names></name><name name-style="western"><surname>Tamm</surname><given-names>M</given-names></name><name name-style="western"><surname>Timmerman</surname><given-names>JA</given-names></name><name name-style="western"><surname>Borger</surname><given-names>P</given-names></name></person-group>. <article-title>House dust mite major allergens Der p 1 and Der p 5 activate human airway-derived epithelial cells by protease-dependent and protease-independent mechanisms</article-title>. <source>Clin Mol Allergy.</source> (<year>2006</year>) <volume>4</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/1476-7961-4-5</pub-id><pub-id pub-id-type="pmid">16569217</pub-id><pub-id pub-id-type="pmcid">PMC1475882</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asokananthan</surname><given-names>N</given-names></name><name name-style="western"><surname>Graham</surname><given-names>PT</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Bakker</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Eidne</surname><given-names>KA</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1</article-title>. <source>J Immunol.</source> (<year>2002</year>) <volume>169</volume>:<fpage>4572</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.169.8.4572</pub-id><pub-id pub-id-type="pmid">12370395</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebeling</surname><given-names>C</given-names></name><name name-style="western"><surname>Forsythe</surname><given-names>P</given-names></name><name name-style="western"><surname>Ng</surname><given-names>J</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>JR</given-names></name><name name-style="western"><surname>Hollenberg</surname><given-names>M</given-names></name><name name-style="western"><surname>Vliagoftis</surname><given-names>H</given-names></name></person-group>. <article-title>Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2005</year>) <volume>115</volume>:<fpage>623</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2004.11.042</pub-id><pub-id pub-id-type="pmid">15753914</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pichavant</surname><given-names>M</given-names></name><name name-style="western"><surname>Charbonnier</surname><given-names>AS</given-names></name><name name-style="western"><surname>Taront</surname><given-names>S</given-names></name><name name-style="western"><surname>Brichet</surname><given-names>A</given-names></name><name name-style="western"><surname>Wallaert</surname><given-names>B</given-names></name><name name-style="western"><surname>Pestel</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Asthmatic bronchial epithelium activated by the proteolytic allergen Der p 1 increases selective dendritic cell recruitment</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2005</year>) <volume>115</volume>:<fpage>771</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2004.11.043</pub-id><pub-id pub-id-type="pmid">15805997</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adam</surname><given-names>E</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>KK</given-names></name><name name-style="western"><surname>Astudillo Fernandez</surname><given-names>O</given-names></name><name name-style="western"><surname>Coulon</surname><given-names>L</given-names></name><name name-style="western"><surname>Bex</surname><given-names>F</given-names></name><name name-style="western"><surname>Duhant</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism</article-title>. <source>J Biol Chem.</source> (<year>2006</year>) <volume>281</volume>:<fpage>6910</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M507140200</pub-id><pub-id pub-id-type="pmid">16293628</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>G</given-names></name><name name-style="western"><surname>Stacey</surname><given-names>MA</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>M</given-names></name><name name-style="western"><surname>Mori</surname><given-names>L</given-names></name><name name-style="western"><surname>Mattoli</surname><given-names>S</given-names></name></person-group>. <article-title>Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells</article-title>. <source>J Immunol.</source> (<year>2001</year>) <volume>167</volume>:<fpage>1014</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.167.2.1014</pub-id><pub-id pub-id-type="pmid">11441110</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asokananthan</surname><given-names>N</given-names></name><name name-style="western"><surname>Graham</surname><given-names>PT</given-names></name><name name-style="western"><surname>Fink</surname><given-names>J</given-names></name><name name-style="western"><surname>Knight</surname><given-names>DA</given-names></name><name name-style="western"><surname>Bakker</surname><given-names>AJ</given-names></name><name name-style="western"><surname>McWilliam</surname><given-names>AS</given-names></name><etal/></person-group>. <article-title>Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells</article-title>. <source>J Immunol.</source> (<year>2002</year>) <volume>168</volume>:<fpage>3577</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.168.7.3577</pub-id><pub-id pub-id-type="pmid">11907122</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knight</surname><given-names>DA</given-names></name><name name-style="western"><surname>Lim</surname><given-names>S</given-names></name><name name-style="western"><surname>Scaffidi</surname><given-names>AK</given-names></name><name name-style="western"><surname>Roche</surname><given-names>N</given-names></name><name name-style="western"><surname>Chung</surname><given-names>KF</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2001</year>) <volume>108</volume>:<fpage>797</fpage>&#8211;<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1067/mai.2001.119025</pub-id><pub-id pub-id-type="pmid">11692107</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cocks</surname><given-names>TM</given-names></name><name name-style="western"><surname>Fong</surname><given-names>B</given-names></name><name name-style="western"><surname>Chow</surname><given-names>JM</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>GP</given-names></name><name name-style="western"><surname>Frauman</surname><given-names>AG</given-names></name><name name-style="western"><surname>Goldie</surname><given-names>RG</given-names></name><etal/></person-group>. <article-title>A protective role for protease-activated receptors in the airways</article-title>. <source>Nature.</source> (<year>1999</year>) <volume>398</volume>:<fpage>156</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/18223</pub-id><pub-id pub-id-type="pmid">10086357</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aubier</surname><given-names>M</given-names></name><name name-style="western"><surname>Thabut</surname><given-names>G</given-names></name><name name-style="western"><surname>Hamidi</surname><given-names>F</given-names></name><name name-style="western"><surname>Guillou</surname><given-names>N</given-names></name><name name-style="western"><surname>Brard</surname><given-names>J</given-names></name><name name-style="western"><surname>Dombret</surname><given-names>MC</given-names></name><etal/></person-group>. <article-title>Airway smooth muscle enlargement is associated with protease-activated receptor 2/ligand overexpression in patients with difficult-to-control severe asthma</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2016</year>) <volume>138</volume>:<fpage>729</fpage>&#8211;<lpage>39</lpage>.e11. <pub-id pub-id-type="doi">10.1016/j.jaci.2015.12.1332</pub-id><pub-id pub-id-type="pmid">27001157</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davidson</surname><given-names>CE</given-names></name><name name-style="western"><surname>Asaduzzaman</surname><given-names>M</given-names></name><name name-style="western"><surname>Arizmendi</surname><given-names>NG</given-names></name><name name-style="western"><surname>Polley</surname><given-names>D</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>Proteinase-activated receptor-2 activation participates in allergic sensitization to house dust mite allergens in a murine model</article-title>. <source>Clin Exper Allergy.</source> (<year>2013</year>) <volume>43</volume>:<fpage>1274</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1111/cea.12185</pub-id><pub-id pub-id-type="pmid">24152160</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Post</surname><given-names>S</given-names></name><name name-style="western"><surname>Heijink</surname><given-names>IH</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>AH</given-names></name><name name-style="western"><surname>de Bruin</surname><given-names>HG</given-names></name><name name-style="western"><surname>van Oosterhout</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Nawijn</surname><given-names>MC</given-names></name></person-group>. <article-title>Protease-activated receptor-2 activation contributes to house dust mite-induced IgE responses in mice</article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e91206</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0091206</pub-id><pub-id pub-id-type="pmid">24651123</pub-id><pub-id pub-id-type="pmcid">PMC3961228</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Campo</surname><given-names>BA</given-names></name><name name-style="western"><surname>Henry</surname><given-names>PJ</given-names></name></person-group>. <article-title>Stimulation of protease-activated receptor-2 inhibits airway eosinophilia, hyperresponsiveness and bronchoconstriction in a murine model of allergic inflammation</article-title>. <source>Br J Pharmacol.</source> (<year>2005</year>) <volume>144</volume>:<fpage>1100</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0706150</pub-id><pub-id pub-id-type="pmid">15700024</pub-id><pub-id pub-id-type="pmcid">PMC1576095</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun-Fahrlander</surname><given-names>C</given-names></name><name name-style="western"><surname>Riedler</surname><given-names>J</given-names></name><name name-style="western"><surname>Herz</surname><given-names>U</given-names></name><name name-style="western"><surname>Eder</surname><given-names>W</given-names></name><name name-style="western"><surname>Waser</surname><given-names>M</given-names></name><name name-style="western"><surname>Grize</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Environmental exposure to endotoxin and its relation to asthma in school-age children</article-title>. <source>N Engl J Med.</source> (<year>2002</year>) <volume>347</volume>:<fpage>869</fpage>&#8211;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa020057</pub-id><pub-id pub-id-type="pmid">12239255</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gereda</surname><given-names>JE</given-names></name><name name-style="western"><surname>Leung</surname><given-names>DY</given-names></name><name name-style="western"><surname>Thatayatikom</surname><given-names>A</given-names></name><name name-style="western"><surname>Streib</surname><given-names>JE</given-names></name><name name-style="western"><surname>Price</surname><given-names>MR</given-names></name><name name-style="western"><surname>Klinnert</surname><given-names>MD</given-names></name><etal/></person-group>. <article-title>Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma</article-title>. <source>Lancet.</source> (<year>2000</year>) <volume>355</volume>:<fpage>1680</fpage>&#8211;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(00)02239-X</pub-id><pub-id pub-id-type="pmid">10905243</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenbarth</surname><given-names>SC</given-names></name><name name-style="western"><surname>Piggott</surname><given-names>DA</given-names></name><name name-style="western"><surname>Huleatt</surname><given-names>JW</given-names></name><name name-style="western"><surname>Visintin</surname><given-names>I</given-names></name><name name-style="western"><surname>Herrick</surname><given-names>CA</given-names></name><name name-style="western"><surname>Bottomly</surname><given-names>K</given-names></name></person-group>. <article-title>Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen</article-title>. <source>J Exp Med.</source> (<year>2002</year>) <volume>196</volume>:<fpage>1645</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20021340</pub-id><pub-id pub-id-type="pmid">12486107</pub-id><pub-id pub-id-type="pmcid">PMC2196061</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lundy</surname><given-names>SK</given-names></name><name name-style="western"><surname>Berlin</surname><given-names>AA</given-names></name><name name-style="western"><surname>Lukacs</surname><given-names>NW</given-names></name></person-group>. <article-title>Interleukin-12-independent down-modulation of cockroach antigen-induced asthma in mice by intranasal exposure to bacterial lipopolysaccharide</article-title>. <source>Am J Pathol.</source> (<year>2003</year>) <volume>163</volume>:<fpage>1961</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63554-7</pub-id><pub-id pub-id-type="pmid">14578195</pub-id><pub-id pub-id-type="pmcid">PMC1892414</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hammad</surname><given-names>H</given-names></name><name name-style="western"><surname>Chieppa</surname><given-names>M</given-names></name><name name-style="western"><surname>Perros</surname><given-names>F</given-names></name><name name-style="western"><surname>Willart</surname><given-names>MA</given-names></name><name name-style="western"><surname>Germain</surname><given-names>RN</given-names></name><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name></person-group>. <article-title>House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells</article-title>. <source>Nat Med.</source> (<year>2009</year>) <volume>15</volume>:<fpage>410</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nm.1946</pub-id><pub-id pub-id-type="pmid">19330007</pub-id><pub-id pub-id-type="pmcid">PMC2789255</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willart</surname><given-names>MA</given-names></name><name name-style="western"><surname>Deswarte</surname><given-names>K</given-names></name><name name-style="western"><surname>Pouliot</surname><given-names>P</given-names></name><name name-style="western"><surname>Braun</surname><given-names>H</given-names></name><name name-style="western"><surname>Beyaert</surname><given-names>R</given-names></name><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name><etal/></person-group>. <article-title>Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33</article-title>. <source>J Exp Med.</source> (<year>2012</year>) <volume>209</volume>:<fpage>1505</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20112691</pub-id><pub-id pub-id-type="pmid">22802353</pub-id><pub-id pub-id-type="pmcid">PMC3409497</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McAlees</surname><given-names>JW</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>GS</given-names></name><name name-style="western"><surname>Harley</surname><given-names>IT</given-names></name><name name-style="western"><surname>Cappelletti</surname><given-names>M</given-names></name><name name-style="western"><surname>Rewerts</surname><given-names>CL</given-names></name><name name-style="western"><surname>Holdcroft</surname><given-names>AM</given-names></name></person-group>. <article-title>Distinct Tlr4-expressing cell compartments control neutrophilic and eosinophilic airway inflammation</article-title>. <source>Mucosal Immunol.</source> (<year>2015</year>) <volume>8</volume>:<fpage>863</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2014.117</pub-id><pub-id pub-id-type="pmid">25465099</pub-id><pub-id pub-id-type="pmcid">PMC4454628</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hristova</surname><given-names>M</given-names></name><name name-style="western"><surname>Habibovic</surname><given-names>A</given-names></name><name name-style="western"><surname>Veith</surname><given-names>C</given-names></name><name name-style="western"><surname>Janssen-Heininger</surname><given-names>YM</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>AE</given-names></name><name name-style="western"><surname>Geiszt</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2016</year>) <volume>137</volume>:<fpage>1545</fpage>&#8211;<lpage>56</lpage>.e11. <pub-id pub-id-type="doi">10.1016/j.jaci.2015.10.003</pub-id><pub-id pub-id-type="pmid">26597162</pub-id><pub-id pub-id-type="pmcid">PMC4860024</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phipps</surname><given-names>S</given-names></name><name name-style="western"><surname>Lam</surname><given-names>CE</given-names></name><name name-style="western"><surname>Kaiko</surname><given-names>GE</given-names></name><name name-style="western"><surname>Foo</surname><given-names>SY</given-names></name><name name-style="western"><surname>Collison</surname><given-names>A</given-names></name><name name-style="western"><surname>Mattes</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>2009</year>) <volume>179</volume>:<fpage>883</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200806-974OC</pub-id><pub-id pub-id-type="pmid">19246719</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>YK</given-names></name><name name-style="western"><surname>Oh</surname><given-names>SY</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>SG</given-names></name><name name-style="western"><surname>Park</surname><given-names>HW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SY</given-names></name><name name-style="western"><surname>Chun</surname><given-names>EY</given-names></name><etal/></person-group>. <article-title>Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma</article-title>. <source>J Immunol.</source> (<year>2007</year>) <volume>178</volume>:<fpage>5375</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.8.5375</pub-id><pub-id pub-id-type="pmid">17404323</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nigo</surname><given-names>YI</given-names></name><name name-style="western"><surname>Yamashita</surname><given-names>M</given-names></name><name name-style="western"><surname>Hirahara</surname><given-names>K</given-names></name><name name-style="western"><surname>Shinnakasu</surname><given-names>R</given-names></name><name name-style="western"><surname>Inami</surname><given-names>M</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2006</year>) <volume>103</volume>:<fpage>2286</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510685103</pub-id><pub-id pub-id-type="pmid">16461458</pub-id><pub-id pub-id-type="pmcid">PMC1413725</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piggott</surname><given-names>DA</given-names></name><name name-style="western"><surname>Eisenbarth</surname><given-names>SC</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Constant</surname><given-names>SL</given-names></name><name name-style="western"><surname>Huleatt</surname><given-names>JW</given-names></name><name name-style="western"><surname>Herrick</surname><given-names>CA</given-names></name><etal/></person-group>. <article-title>MyD88-dependent induction of allergic Th2 responses to intranasal antigen</article-title>. <source>J Clin Investig.</source> (<year>2005</year>) <volume>115</volume>:<fpage>459</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1172/JCI200522462</pub-id><pub-id pub-id-type="pmid">15650773</pub-id><pub-id pub-id-type="pmcid">PMC544038</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>HP</given-names></name><name name-style="western"><surname>Kline</surname><given-names>JN</given-names></name><name name-style="western"><surname>Penisten</surname><given-names>A</given-names></name><name name-style="western"><surname>Apicella</surname><given-names>MA</given-names></name><name name-style="western"><surname>Gioannini</surname><given-names>TL</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2</article-title>. <source>Am J Physiol Lung Cell Mol Physiol.</source> (<year>2004</year>). <volume>287</volume>:<fpage>L428</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00377.2003</pub-id><pub-id pub-id-type="pmid">15121639</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stremnitzer</surname><given-names>C</given-names></name><name name-style="western"><surname>Manzano-Szalai</surname><given-names>K</given-names></name><name name-style="western"><surname>Starkl</surname><given-names>P</given-names></name><name name-style="western"><surname>Willensdorfer</surname><given-names>A</given-names></name><name name-style="western"><surname>Schrom</surname><given-names>S</given-names></name><name name-style="western"><surname>Singer</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Epicutaneously applied Der p 2 induces a strong TH 2-biased antibody response in C57BL/6 mice, independent of functional TLR4</article-title>. <source>Allergy.</source> (<year>2014</year>) <volume>69</volume>:<fpage>741</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1111/all.12399</pub-id><pub-id pub-id-type="pmid">24735481</pub-id><pub-id pub-id-type="pmcid">PMC4023119</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodgkinson</surname><given-names>CP</given-names></name><name name-style="western"><surname>Patel</surname><given-names>K</given-names></name><name name-style="western"><surname>Ye</surname><given-names>S</given-names></name></person-group>. <article-title>Functional Toll-like receptor 4 mutations modulate the response to fibrinogen</article-title>. <source>Thromb Haemost.</source> (<year>2008</year>) <volume>100</volume>:<fpage>301</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1160/TH08-03-0179</pub-id><pub-id pub-id-type="pmid">18690351</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zambetti</surname><given-names>LP</given-names></name><name name-style="western"><surname>Laudisi</surname><given-names>F</given-names></name><name name-style="western"><surname>Licandro</surname><given-names>G</given-names></name><name name-style="western"><surname>Ricciardi-Castagnoli</surname><given-names>P</given-names></name><name name-style="western"><surname>Mortellaro</surname><given-names>A</given-names></name></person-group>. <article-title>The rhapsody of NLRPs: master players of inflammation and a lot more</article-title>. <source>Immunol Res.</source> (<year>2012</year>) <volume>53</volume>:<fpage>78</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1007/s12026-012-8272-z</pub-id><pub-id pub-id-type="pmid">22427013</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><name name-style="western"><surname>Wong</surname><given-names>MT</given-names></name><name name-style="western"><surname>Stowe</surname><given-names>IB</given-names></name><name name-style="western"><surname>Ramani</surname><given-names>SR</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>LC</given-names></name><name name-style="western"><surname>Akashi-Takamura</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Noncanonical inflammasome activation by intracellular LPS independent of TLR4</article-title>. <source>Science.</source> (<year>2013</year>) <volume>341</volume>:<fpage>1246</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1126/science.1240248</pub-id><pub-id pub-id-type="pmid">23887873</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proell</surname><given-names>M</given-names></name><name name-style="western"><surname>Gerlic</surname><given-names>M</given-names></name><name name-style="western"><surname>Mace</surname><given-names>PD</given-names></name><name name-style="western"><surname>Reed</surname><given-names>JC</given-names></name><name name-style="western"><surname>Riedl</surname><given-names>SJ</given-names></name></person-group>. <article-title>The CARD plays a critical role in ASC foci formation and inflammasome signalling</article-title>. <source>Biochem J.</source> (<year>2013</year>) <volume>449</volume>:<fpage>613</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20121198</pub-id><pub-id pub-id-type="pmid">23110696</pub-id><pub-id pub-id-type="pmcid">PMC3966062</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinon</surname><given-names>F</given-names></name><name name-style="western"><surname>Burns</surname><given-names>K</given-names></name><name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name></person-group>. <article-title>The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta</article-title>. <source>Mol Cell.</source> (<year>2002</year>) <volume>10</volume>:<fpage>417</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/S1097-2765(02)00599-3</pub-id><pub-id pub-id-type="pmid">12191486</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kool</surname><given-names>M</given-names></name><name name-style="western"><surname>Willart</surname><given-names>MA</given-names></name><name name-style="western"><surname>van Nimwegen</surname><given-names>M</given-names></name><name name-style="western"><surname>Bergen</surname><given-names>I</given-names></name><name name-style="western"><surname>Pouliot</surname><given-names>P</given-names></name><name name-style="western"><surname>Virchow</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma</article-title>. <source>Immunity.</source> (<year>2011</year>) <volume>34</volume>:<fpage>527</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2011.03.015</pub-id><pub-id pub-id-type="pmid">21474346</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinon</surname><given-names>F</given-names></name><name name-style="western"><surname>Petrilli</surname><given-names>V</given-names></name><name name-style="western"><surname>Mayor</surname><given-names>A</given-names></name><name name-style="western"><surname>Tardivel</surname><given-names>A</given-names></name><name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name></person-group>. <article-title>Gout-associated uric acid crystals activate the NALP3 inflammasome</article-title>. <source>Nature.</source> (<year>2006</year>) <volume>440</volume>:<fpage>237</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/nature04516</pub-id><pub-id pub-id-type="pmid">16407889</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madouri</surname><given-names>F</given-names></name><name name-style="western"><surname>Guillou</surname><given-names>N</given-names></name><name name-style="western"><surname>Fauconnier</surname><given-names>L</given-names></name><name name-style="western"><surname>Marchiol</surname><given-names>T</given-names></name><name name-style="western"><surname>Rouxel</surname><given-names>N</given-names></name><name name-style="western"><surname>Chenuet</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation</article-title>. <source>J Mol Cell Biol.</source> (<year>2015</year>) <volume>7</volume>:<fpage>351</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1093/jmcb/mjv012</pub-id><pub-id pub-id-type="pmid">25714839</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aachoui</surname><given-names>Y</given-names></name><name name-style="western"><surname>Leaf</surname><given-names>IA</given-names></name><name name-style="western"><surname>Hagar</surname><given-names>JA</given-names></name><name name-style="western"><surname>Fontana</surname><given-names>MF</given-names></name><name name-style="western"><surname>Campos</surname><given-names>CG</given-names></name><name name-style="western"><surname>Zak</surname><given-names>DE</given-names></name><etal/></person-group>. <article-title>Caspase-11 protects against bacteria that escape the vacuole</article-title>. <source>Science.</source> (<year>2013</year>) <volume>339</volume>:<fpage>975</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.1230751</pub-id><pub-id pub-id-type="pmid">23348507</pub-id><pub-id pub-id-type="pmcid">PMC3697099</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><name name-style="western"><surname>Warming</surname><given-names>S</given-names></name><name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name><name name-style="western"><surname>Vande Walle</surname><given-names>L</given-names></name><name name-style="western"><surname>Louie</surname><given-names>S</given-names></name><name name-style="western"><surname>Dong</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Non-canonical inflammasome activation targets caspase-11</article-title>. <source>Nature.</source> (<year>2011</year>) <volume>479</volume>:<fpage>117</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/nature10558</pub-id><pub-id pub-id-type="pmid">22002608</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name><name name-style="western"><surname>Declercq</surname><given-names>W</given-names></name><name name-style="western"><surname>Kalai</surname><given-names>M</given-names></name><name name-style="western"><surname>Saelens</surname><given-names>X</given-names></name><name name-style="western"><surname>Vandenabeele</surname><given-names>P</given-names></name></person-group>. <article-title>Alice in caspase land. A phylogenetic analysis of caspases from worm to man</article-title>. <source>Cell Death Differ.</source> (<year>2002</year>) <volume>9</volume>:<fpage>358</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4400989</pub-id><pub-id pub-id-type="pmid">11965488</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinon</surname><given-names>F</given-names></name><name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name></person-group>. <article-title>Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases</article-title>. <source>Cell.</source> (<year>2004</year>) <volume>117</volume>:<fpage>561</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.05.004</pub-id><pub-id pub-id-type="pmid">15163405</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faucheu</surname><given-names>C</given-names></name><name name-style="western"><surname>Diu</surname><given-names>A</given-names></name><name name-style="western"><surname>Chan</surname><given-names>AW</given-names></name><name name-style="western"><surname>Blanchet</surname><given-names>AM</given-names></name><name name-style="western"><surname>Miossec</surname><given-names>C</given-names></name><name name-style="western"><surname>Herve</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells</article-title>. <source>EMBO J.</source> (<year>1995</year>) <volume>14</volume>:<fpage>1914</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb07183.x</pub-id><pub-id pub-id-type="pmid">7743998</pub-id><pub-id pub-id-type="pmcid">PMC398290</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamens</surname><given-names>J</given-names></name><name name-style="western"><surname>Paskind</surname><given-names>M</given-names></name><name name-style="western"><surname>Hugunin</surname><given-names>M</given-names></name><name name-style="western"><surname>Talanian</surname><given-names>RV</given-names></name><name name-style="western"><surname>Allen</surname><given-names>H</given-names></name><name name-style="western"><surname>Banach</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases</article-title>. <source>J Biol Chem.</source> (<year>1995</year>) <volume>270</volume>:<fpage>15250</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.25.15250</pub-id><pub-id pub-id-type="pmid">7797510</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munday</surname><given-names>NA</given-names></name><name name-style="western"><surname>Vaillancourt</surname><given-names>JP</given-names></name><name name-style="western"><surname>Ali</surname><given-names>A</given-names></name><name name-style="western"><surname>Casano</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Miller</surname><given-names>DK</given-names></name><name name-style="western"><surname>Molineaux</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases</article-title>. <source>J Biol Chem.</source> (<year>1995</year>) <volume>270</volume>:<fpage>15870</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.26.15870</pub-id><pub-id pub-id-type="pmid">7797592</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faucheu</surname><given-names>C</given-names></name><name name-style="western"><surname>Blanchet</surname><given-names>AM</given-names></name><name name-style="western"><surname>Collard-Dutilleul</surname><given-names>V</given-names></name><name name-style="western"><surname>Lalanne</surname><given-names>JL</given-names></name><name name-style="western"><surname>Diu-Hercend</surname><given-names>A</given-names></name></person-group>. <article-title>Identification of a cysteine protease closely related to interleukin-1 beta-converting enzyme</article-title>. <source>Eur J Biochem.</source> (<year>1996</year>) <volume>236</volume>:<fpage>207</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1996.t01-1-00207.x</pub-id><pub-id pub-id-type="pmid">8617266</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Miura</surname><given-names>M</given-names></name><name name-style="western"><surname>Jung</surname><given-names>YK</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>E</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name></person-group>. <article-title>Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE</article-title>. <source>Cell.</source> (<year>1998</year>) <volume>92</volume>:<fpage>501</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80943-5</pub-id><pub-id pub-id-type="pmid">9491891</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>XY</given-names></name><name name-style="western"><surname>Choi</surname><given-names>MS</given-names></name><name name-style="western"><surname>Porter</surname><given-names>AG</given-names></name></person-group>. <article-title>Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma</article-title>. <source>J Biol Chem.</source> (<year>2000</year>) <volume>275</volume>:<fpage>39920</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M007255200</pub-id><pub-id pub-id-type="pmid">10986288</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broz</surname><given-names>P</given-names></name><name name-style="western"><surname>Ruby</surname><given-names>T</given-names></name><name name-style="western"><surname>Belhocine</surname><given-names>K</given-names></name><name name-style="western"><surname>Bouley</surname><given-names>DM</given-names></name><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><name name-style="western"><surname>Dixit</surname><given-names>VM</given-names></name><etal/></person-group>. <article-title>Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1</article-title>. <source>Nature.</source> (<year>2012</year>) <volume>490</volume>:<fpage>288</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/nature11419</pub-id><pub-id pub-id-type="pmid">22895188</pub-id><pub-id pub-id-type="pmcid">PMC3470772</pub-id></mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gurung</surname><given-names>P</given-names></name><name name-style="western"><surname>Malireddi</surname><given-names>RK</given-names></name><name name-style="western"><surname>Anand</surname><given-names>PK</given-names></name><name name-style="western"><surname>Demon</surname><given-names>D</given-names></name><name name-style="western"><surname>Vande Walle</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-beta (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens</article-title>. <source>J Biol Chem.</source> (<year>2012</year>) <volume>287</volume>:<fpage>34474</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.401406</pub-id><pub-id pub-id-type="pmid">22898816</pub-id><pub-id pub-id-type="pmcid">PMC3464552</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rathinam</surname><given-names>VA</given-names></name><name name-style="western"><surname>Vanaja</surname><given-names>SK</given-names></name><name name-style="western"><surname>Waggoner</surname><given-names>L</given-names></name><name name-style="western"><surname>Sokolovska</surname><given-names>A</given-names></name><name name-style="western"><surname>Becker</surname><given-names>C</given-names></name><name name-style="western"><surname>Stuart</surname><given-names>LM</given-names></name><etal/></person-group>. <article-title>TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria</article-title>. <source>Cell.</source> (<year>2012</year>) <volume>150</volume>:<fpage>606</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.07.007</pub-id><pub-id pub-id-type="pmid">22819539</pub-id><pub-id pub-id-type="pmcid">PMC3660860</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bauernfeind</surname><given-names>FG</given-names></name><name name-style="western"><surname>Horvath</surname><given-names>G</given-names></name><name name-style="western"><surname>Stutz</surname><given-names>A</given-names></name><name name-style="western"><surname>Alnemri</surname><given-names>ES</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>K</given-names></name><name name-style="western"><surname>Speert</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression</article-title>. <source>J Immunol.</source> (<year>2009</year>) <volume>183</volume>:<fpage>787</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0901363</pub-id><pub-id pub-id-type="pmid">19570822</pub-id><pub-id pub-id-type="pmcid">PMC2824855</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenbarth</surname><given-names>SC</given-names></name><name name-style="western"><surname>Colegio</surname><given-names>OR</given-names></name><name name-style="western"><surname>O'Connor</surname><given-names>W</given-names></name><name name-style="western"><surname>Sutterwala</surname><given-names>FS</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name></person-group>. <article-title>Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants</article-title>. <source>Nature.</source> (<year>2008</year>) <volume>453</volume>:<fpage>1122</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nature06939</pub-id><pub-id pub-id-type="pmid">18496530</pub-id><pub-id pub-id-type="pmcid">PMC4804622</pub-id></mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Besnard</surname><given-names>AG</given-names></name><name name-style="western"><surname>Guillou</surname><given-names>N</given-names></name><name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name><name name-style="western"><surname>Erard</surname><given-names>F</given-names></name><name name-style="western"><surname>Couillin</surname><given-names>I</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant</article-title>. <source>Allergy.</source> (<year>2011</year>) <volume>66</volume>:<fpage>1047</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1111/j.1398-9995.2011.02586.x</pub-id><pub-id pub-id-type="pmid">21443539</pub-id></mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caution</surname><given-names>K</given-names></name><name name-style="western"><surname>Young</surname><given-names>N</given-names></name><name name-style="western"><surname>Robledo-Avila</surname><given-names>F</given-names></name><name name-style="western"><surname>Krause</surname><given-names>K</given-names></name><name name-style="western"><surname>Abu Khweek</surname><given-names>A</given-names></name><name name-style="western"><surname>Hamilton</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Caspase-11 mediates neutrophil chemotaxis and extracellular trap formation during acute gouty arthritis through alteration of cofilin phosphorylation</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>2519</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.02519</pub-id><pub-id pub-id-type="pmid">31803174</pub-id><pub-id pub-id-type="pmcid">PMC6874099</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Brieher</surname><given-names>WM</given-names></name><name name-style="western"><surname>Scimone</surname><given-names>ML</given-names></name><name name-style="western"><surname>Kang</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yin</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization</article-title>. <source>Nat Cell Biol.</source> (<year>2007</year>) <volume>9</volume>:<fpage>276</fpage>&#8211;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1541</pub-id><pub-id pub-id-type="pmid">17293856</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaslona</surname><given-names>Z</given-names></name><name name-style="western"><surname>Flis</surname><given-names>E</given-names></name><name name-style="western"><surname>Wilk</surname><given-names>MM</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>RG</given-names></name><name name-style="western"><surname>Palsson-McDermott</surname><given-names>EM</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>MM</given-names></name><etal/></person-group>. <article-title>Caspase-11 promotes allergic airway inflammation</article-title>. <source>Nat Commun.</source> (<year>2020</year>) <volume>11</volume>:<fpage>1055</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-14945-2</pub-id><pub-id pub-id-type="pmid">32103022</pub-id><pub-id pub-id-type="pmcid">PMC7044193</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mindt</surname><given-names>BC</given-names></name><name name-style="western"><surname>Fritz</surname><given-names>JH</given-names></name><name name-style="western"><surname>Duerr</surname><given-names>CU</given-names></name></person-group><article-title>Group 2 innate lymphoid cells in pulmonary immunity and tissue homeostasis</article-title>. <source>Front Immunol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>840</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00840</pub-id><pub-id pub-id-type="pmid">29760695</pub-id><pub-id pub-id-type="pmcid">PMC5937028</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duerr</surname><given-names>CU</given-names></name><name name-style="western"><surname>Fritz</surname><given-names>JH</given-names></name></person-group>. <article-title>Isolation of Group 2 Innate Lymphoid Cells from Mouse Lungs</article-title>. <source>Innate Antiv Immun.</source> (<year>2017</year>) <volume>1656</volume>:<fpage>253</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-7237-1_16</pub-id><pub-id pub-id-type="pmid">28808975</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SG</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><name name-style="western"><surname>Kjarsgaard</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name><name name-style="western"><surname>Oliveria</surname><given-names>JP</given-names></name><name name-style="western"><surname>O'Byrne</surname><given-names>PM</given-names></name><etal/></person-group>. <article-title>Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2016</year>) <volume>137</volume>:<fpage>75</fpage>&#8211;<lpage>86</lpage>.e8. <pub-id pub-id-type="doi">10.1016/j.jaci.2015.05.037</pub-id><pub-id pub-id-type="pmid">26194544</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>BWS</given-names></name><name name-style="western"><surname>de Bruijn</surname><given-names>MJW</given-names></name><name name-style="western"><surname>Tindemans</surname><given-names>I</given-names></name><name name-style="western"><surname>Lukkes</surname><given-names>M</given-names></name><name name-style="western"><surname>KleinJan</surname><given-names>A</given-names></name><name name-style="western"><surname>Hoogsteden</surname><given-names>HC</given-names></name><etal/></person-group>. <article-title>T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice</article-title>. <source>Eur J Immunol.</source> (<year>2016</year>) <volume>46</volume>:<fpage>1392</fpage>&#8211;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201546119</pub-id><pub-id pub-id-type="pmid">27062360</pub-id></mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Rijt</surname><given-names>LS</given-names></name><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name></person-group>. <article-title>Dendritic cells in asthma: a function beyond sensitization</article-title>. <source>Clin Exper Allergy.</source> (<year>2005</year>) <volume>35</volume>:<fpage>1125</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2222.2005.02321.x</pub-id><pub-id pub-id-type="pmid">16164437</pub-id></mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roelandt</surname><given-names>T</given-names></name><name name-style="western"><surname>Heughebaert</surname><given-names>C</given-names></name><name name-style="western"><surname>Hachem</surname><given-names>JP</given-names></name></person-group>. <article-title>Proteolytically active allergens cause barrier breakdown</article-title>. <source>J Invest Dermatol.</source> (<year>2008</year>) <volume>128</volume>:<fpage>1878</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2008.168</pub-id><pub-id pub-id-type="pmid">18626479</pub-id></mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nathan</surname><given-names>AT</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>EA</given-names></name><name name-style="western"><surname>Chakir</surname><given-names>J</given-names></name><name name-style="western"><surname>Wills-Karp</surname><given-names>M</given-names></name></person-group>. <article-title>Innate immune responses of airway epithelium to house dust mite are mediated through beta-glucan-dependent pathways</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2009</year>) <volume>123</volume>:<fpage>612</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2008.12.006</pub-id><pub-id pub-id-type="pmid">19178937</pub-id><pub-id pub-id-type="pmcid">PMC2761684</pub-id></mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>NA</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>OM</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>JM</given-names></name><name name-style="western"><surname>Parsons</surname><given-names>MW</given-names></name><name name-style="western"><surname>Xing</surname><given-names>W</given-names></name><name name-style="western"><surname>Austen</surname><given-names>KF</given-names></name><etal/></person-group>. <article-title>Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes</article-title>. <source>J Exp Med.</source> (<year>2011</year>) <volume>208</volume>:<fpage>593</fpage>&#8211;<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20100793</pub-id><pub-id pub-id-type="pmid">21357742</pub-id><pub-id pub-id-type="pmcid">PMC3058587</pub-id></mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>T</given-names></name><name name-style="western"><surname>Hirose</surname><given-names>K</given-names></name><name name-style="western"><surname>Norimoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Tamachi</surname><given-names>T</given-names></name><name name-style="western"><surname>Yokota</surname><given-names>M</given-names></name><name name-style="western"><surname>Saku</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Dectin-1 plays an important role in house dust mite-induced allergic airway inflammation through the activation of CD11b+ dendritic cells</article-title>. <source>J Immunol.</source> (<year>2017</year>) <volume>198</volume>:<fpage>61</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1502393</pub-id><pub-id pub-id-type="pmid">27852745</pub-id></mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>CG</given-names></name><name name-style="western"><surname>Da Silva</surname><given-names>CA</given-names></name><name name-style="western"><surname>Dela Cruz</surname><given-names>CS</given-names></name><name name-style="western"><surname>Ahangari</surname><given-names>F</given-names></name><name name-style="western"><surname>Ma</surname><given-names>B</given-names></name><name name-style="western"><surname>Kang</surname><given-names>MJ</given-names></name><etal/></person-group>. <article-title>Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury</article-title>. <source>Ann Rev Physiol.</source> (<year>2011</year>) <volume>73</volume>:<fpage>479</fpage>&#8211;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-012110-142250</pub-id><pub-id pub-id-type="pmid">21054166</pub-id><pub-id pub-id-type="pmcid">PMC3864643</pub-id></mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reese</surname><given-names>TA</given-names></name><name name-style="western"><surname>Liang</surname><given-names>HE</given-names></name><name name-style="western"><surname>Tager</surname><given-names>AM</given-names></name><name name-style="western"><surname>Luster</surname><given-names>AD</given-names></name><name name-style="western"><surname>Van Rooijen</surname><given-names>N</given-names></name><name name-style="western"><surname>Voehringer</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Chitin induces accumulation in tissue of innate immune cells associated with allergy</article-title>. <source>Nature.</source> (<year>2007</year>) <volume>447</volume>:<fpage>92</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nature05746</pub-id><pub-id pub-id-type="pmid">17450126</pub-id><pub-id pub-id-type="pmcid">PMC2527589</pub-id></mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herbert</surname><given-names>CA</given-names></name><name name-style="western"><surname>King</surname><given-names>CM</given-names></name><name name-style="western"><surname>Ring</surname><given-names>PC</given-names></name><name name-style="western"><surname>Holgate</surname><given-names>ST</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>GA</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p1</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>1995</year>) <volume>12</volume>:<fpage>369</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1165/ajrcmb.12.4.7695916</pub-id><pub-id pub-id-type="pmid">7695916</pub-id></mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maruo</surname><given-names>K</given-names></name><name name-style="western"><surname>Akaike</surname><given-names>T</given-names></name><name name-style="western"><surname>Ono</surname><given-names>T</given-names></name><name name-style="western"><surname>Okamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Maeda</surname><given-names>H</given-names></name></person-group>. <article-title>Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease</article-title>. <source>J Allergy Clin Immunol.</source> (<year>1997</year>) <volume>100</volume>:<fpage>253</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-6749(97)70233-1</pub-id><pub-id pub-id-type="pmid">9275149</pub-id></mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Royer</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Emara</surname><given-names>M</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Al-Ghouleh</surname><given-names>A</given-names></name><name name-style="western"><surname>Tighe</surname><given-names>P</given-names></name><name name-style="western"><surname>Jones</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>The mannose receptor mediates the uptake of diverse native allergens by dendritic cells and determines allergen-induced T cell polarization through modulation of IDO activity</article-title>. <source>J Immunol.</source> (<year>2010</year>) <volume>185</volume>:<fpage>1522</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1000774</pub-id><pub-id pub-id-type="pmid">20610655</pub-id></mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emara</surname><given-names>M</given-names></name><name name-style="western"><surname>Royer</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Mahdavi</surname><given-names>J</given-names></name><name name-style="western"><surname>Shakib</surname><given-names>F</given-names></name><name name-style="western"><surname>Ghaemmaghami</surname><given-names>AM</given-names></name></person-group><article-title>Retagging identifies dendritic cell-specific intercellular adhesion molecule-3 (ICAM3)-grabbing non-integrin (DC-SIGN) protein as a novel receptor for a major allergen from house dust mite</article-title>. <source>J Biol Chem.</source> (<year>2012</year>) <volume>287</volume>:<fpage>5756</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.312520</pub-id><pub-id pub-id-type="pmid">22205703</pub-id><pub-id pub-id-type="pmcid">PMC3285347</pub-id></mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Beck</surname><given-names>L</given-names></name><name name-style="western"><surname>Rossetto</surname><given-names>C</given-names></name><name name-style="western"><surname>Gong</surname><given-names>X</given-names></name><name name-style="western"><surname>Takikawa</surname><given-names>O</given-names></name><name name-style="western"><surname>Takabayashi</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Inhibition of experimental asthma by indoleamine 2,3-dioxygenase</article-title>. <source>J Clin Investig.</source> (<year>2004</year>) <volume>114</volume>:<fpage>270</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1172/JCI21275</pub-id><pub-id pub-id-type="pmid">15254594</pub-id><pub-id pub-id-type="pmcid">PMC449749</pub-id></mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taher</surname><given-names>YA</given-names></name><name name-style="western"><surname>Piavaux</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Gras</surname><given-names>R</given-names></name><name name-style="western"><surname>van Esch</surname><given-names>BC</given-names></name><name name-style="western"><surname>Hofman</surname><given-names>GA</given-names></name><name name-style="western"><surname>Bloksma</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2008</year>) <volume>121</volume>:<fpage>983</fpage>&#8211;<lpage>91</lpage>.e2. <pub-id pub-id-type="doi">10.1016/j.jaci.2007.11.021</pub-id><pub-id pub-id-type="pmid">18179817</pub-id></mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chapman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Wunschmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Pomes</surname><given-names>A</given-names></name></person-group>. <article-title>Proteases as Th2 adjuvants</article-title>. <source>Curr Allergy Asthma Rep.</source> (<year>2007</year>) <volume>7</volume>:<fpage>363</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s11882-007-0055-6</pub-id><pub-id pub-id-type="pmid">17697645</pub-id></mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulz</surname><given-names>O</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>HF</given-names></name><name name-style="western"><surname>Shakib</surname><given-names>F</given-names></name></person-group>. <article-title>Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity</article-title>. <source>J Exp Med.</source> (<year>1998</year>) <volume>187</volume>:<fpage>271</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1084/jem.187.2.271</pub-id><pub-id pub-id-type="pmid">9432986</pub-id><pub-id pub-id-type="pmcid">PMC2212095</pub-id></mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diehl</surname><given-names>S</given-names></name><name name-style="western"><surname>Rincon</surname><given-names>M</given-names></name></person-group>. <article-title>The two faces of IL-6 on Th1/Th2 differentiation</article-title>. <source>Mol Immunol.</source> (<year>2002</year>) <volume>39</volume>:<fpage>531</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S0161-5890(02)00210-9</pub-id><pub-id pub-id-type="pmid">12431386</pub-id></mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghaemmaghami</surname><given-names>AM</given-names></name><name name-style="western"><surname>Gough</surname><given-names>L</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>HF</given-names></name><name name-style="western"><surname>Shakib</surname><given-names>F</given-names></name></person-group>. <article-title>The proteolytic activity of the major dust mite allergen Der p 1 conditions dendritic cells to produce less interleukin-12: allergen-induced Th2 bias determined at the dendritic cell level</article-title>. <source>Clin Exper Allergy.</source> (<year>2002</year>) <volume>32</volume>:<fpage>1468</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2745.2002.01504.x</pub-id><pub-id pub-id-type="pmid">12372127</pub-id></mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smits</surname><given-names>HH</given-names></name><name name-style="western"><surname>Gloudemans</surname><given-names>AK</given-names></name><name name-style="western"><surname>van Nimwegen</surname><given-names>M</given-names></name><name name-style="western"><surname>Willart</surname><given-names>MA</given-names></name><name name-style="western"><surname>Soullie</surname><given-names>T</given-names></name><name name-style="western"><surname>Muskens</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Cholera toxin B suppresses allergic inflammation through induction of secretory IgA</article-title>. <source>Mucosal Immunol.</source> (<year>2009</year>) <volume>2</volume>:<fpage>331</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2009.16</pub-id><pub-id pub-id-type="pmid">19404246</pub-id></mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gloudemans</surname><given-names>AK</given-names></name><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name><name name-style="western"><surname>Smits</surname><given-names>HH</given-names></name></person-group>. <article-title>Potential of immunoglobulin A to prevent allergic asthma</article-title>. <source>Clin Dev Immunol.</source> (<year>2013</year>) <volume>2013</volume>:<fpage>542091</fpage>. <pub-id pub-id-type="doi">10.1155/2013/542091</pub-id><pub-id pub-id-type="pmid">23690823</pub-id><pub-id pub-id-type="pmcid">PMC3649226</pub-id></mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dodev</surname><given-names>TS</given-names></name><name name-style="western"><surname>Bowen</surname><given-names>H</given-names></name><name name-style="western"><surname>Shamji</surname><given-names>MH</given-names></name><name name-style="western"><surname>Bax</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Beavil</surname><given-names>AJ</given-names></name><name name-style="western"><surname>McDonnell</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>Inhibition of allergen-dependent IgE activity by antibodies of the same specificity but different class</article-title>. <source>Allergy.</source> (<year>2015</year>) <volume>70</volume>:<fpage>720</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1111/all.12607</pub-id><pub-id pub-id-type="pmid">25758595</pub-id><pub-id pub-id-type="pmcid">PMC4949685</pub-id></mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gough</surname><given-names>L</given-names></name><name name-style="western"><surname>Schulz</surname><given-names>O</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>HF</given-names></name><name name-style="western"><surname>Shakib</surname><given-names>F</given-names></name></person-group>. <article-title>The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response</article-title>. <source>J Exp Med.</source> (<year>1999</year>) <volume>190</volume>:<fpage>1897</fpage>&#8211;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1084/jem.190.12.1897</pub-id><pub-id pub-id-type="pmid">10601364</pub-id><pub-id pub-id-type="pmcid">PMC2195724</pub-id></mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weskamp</surname><given-names>G</given-names></name><name name-style="western"><surname>Ford</surname><given-names>JW</given-names></name><name name-style="western"><surname>Sturgill</surname><given-names>J</given-names></name><name name-style="western"><surname>Martin</surname><given-names>S</given-names></name><name name-style="western"><surname>Docherty</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Swendeman</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23</article-title>. <source>Nat Immunol.</source> (<year>2006</year>) <volume>7</volume>:<fpage>1293</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ni1399</pub-id><pub-id pub-id-type="pmid">17072319</pub-id></mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuchs</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Matzinger</surname><given-names>P</given-names></name></person-group><article-title>B cells turn off virgin but not memory T cells</article-title>. <source>Science.</source> (<year>1992</year>) <volume>258</volume>:<fpage>1156</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1126/science.1439825</pub-id><pub-id pub-id-type="pmid">1439825</pub-id></mixed-citation></ref><ref id="B151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Constant</surname><given-names>S</given-names></name><name name-style="western"><surname>Schweitzer</surname><given-names>N</given-names></name><name name-style="western"><surname>West</surname><given-names>J</given-names></name><name name-style="western"><surname>Ranney</surname><given-names>P</given-names></name><name name-style="western"><surname>Bottomly</surname><given-names>K</given-names></name></person-group>. <article-title>B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens <italic toggle="yes">in vivo</italic></article-title>. <source>J Immunol</source>. (<year>1995</year>) <volume>155</volume>:<fpage>3734</fpage>&#8211;<lpage>41</lpage>.<pub-id pub-id-type="pmid">7561077</pub-id></mixed-citation></ref><ref id="B152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dullaers</surname><given-names>M</given-names></name><name name-style="western"><surname>Schuijs</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Willart</surname><given-names>M</given-names></name><name name-style="western"><surname>Fierens</surname><given-names>K</given-names></name><name name-style="western"><surname>Van Moorleghem</surname><given-names>J</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>House dust mite-driven asthma and allergen-specific T cells depend on B cells when the amount of inhaled allergen is limiting</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2017</year>) <volume>140</volume>:<fpage>76</fpage>&#8211;<lpage>88</lpage>.e7. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.09.020</pub-id><pub-id pub-id-type="pmid">27746238</pub-id></mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurmatov</surname><given-names>U</given-names></name><name name-style="western"><surname>van Schayck</surname><given-names>CP</given-names></name><name name-style="western"><surname>Hurwitz</surname><given-names>B</given-names></name><name name-style="western"><surname>Sheikh</surname><given-names>A</given-names></name></person-group>. <article-title>House dust mite avoidance measures for perennial allergic rhinitis: an updated cochrane systematic review</article-title>. <source>Allergy.</source> (<year>2012</year>) <volume>67</volume>:<fpage>158</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1111/j.1398-9995.2011.02752.x</pub-id><pub-id pub-id-type="pmid">22103686</pub-id></mixed-citation></ref><ref id="B154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gotzsche</surname><given-names>PC</given-names></name><name name-style="western"><surname>Johansen</surname><given-names>HK</given-names></name></person-group>. <article-title>House dust mite control measures for asthma: systematic review</article-title>. <source>Allergy.</source> (<year>2008</year>) <volume>63</volume>:<fpage>646</fpage>&#8211;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1111/j.1398-9995.2008.01690.x</pub-id><pub-id pub-id-type="pmid">18445182</pub-id></mixed-citation></ref><ref id="B155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bousquet</surname><given-names>J</given-names></name><name name-style="western"><surname>Khaltaev</surname><given-names>N</given-names></name><name name-style="western"><surname>Cruz</surname><given-names>AA</given-names></name><name name-style="western"><surname>Denburg</surname><given-names>J</given-names></name><name name-style="western"><surname>Fokkens</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Togias</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)</article-title>. <source>Allergy.</source> (<year>2008</year>) <volume>63</volume>(<issue>Suppl. 86</issue>):<fpage>8</fpage>&#8211;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1111/j.1398-9995.2007.01620.x</pub-id><pub-id pub-id-type="pmid">18331513</pub-id></mixed-citation></ref><ref id="B156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>James</surname><given-names>LK</given-names></name><name name-style="western"><surname>Durham</surname><given-names>SR</given-names></name></person-group>. <article-title>Update on mechanisms of allergen injection immunotherapy</article-title>. <source>Clin Exper Allergy.</source> (<year>2008</year>) <volume>38</volume>:<fpage>1074</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2222.2008.02976.x</pub-id><pub-id pub-id-type="pmid">18691292</pub-id></mixed-citation></ref><ref id="B157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gold</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Antignano</surname><given-names>F</given-names></name><name name-style="western"><surname>Halim</surname><given-names>TY</given-names></name><name name-style="western"><surname>Hirota</surname><given-names>JA</given-names></name><name name-style="western"><surname>Blanchet</surname><given-names>MR</given-names></name><name name-style="western"><surname>Zaph</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2014</year>) <volume>133</volume>:<fpage>1142</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2014.02.033</pub-id><pub-id pub-id-type="pmid">24679471</pub-id></mixed-citation></ref><ref id="B158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mueller</surname><given-names>RS</given-names></name></person-group>. <article-title>Update on allergen immunotherapy</article-title>. <source>Vet Clin North Am Small Anim Pract.</source> (<year>2019</year>) <volume>49</volume>:<fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.cvsm.2018.08.001</pub-id><pub-id pub-id-type="pmid">30227970</pub-id></mixed-citation></ref><ref id="B159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scadding</surname><given-names>G</given-names></name><name name-style="western"><surname>Durham</surname><given-names>S</given-names></name></person-group>. <article-title>Mechanisms of sublingual immunotherapy</article-title>. <source>J Asthma.</source> (<year>2009</year>) <volume>46</volume>:<fpage>322</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1080/02770900902785729</pub-id><pub-id pub-id-type="pmid">19484663</pub-id></mixed-citation></ref><ref id="B160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bousquet</surname><given-names>J</given-names></name><name name-style="western"><surname>Hejjaoui</surname><given-names>A</given-names></name><name name-style="western"><surname>Clauzel</surname><given-names>AM</given-names></name><name name-style="western"><surname>Guerin</surname><given-names>B</given-names></name><name name-style="western"><surname>Dhivert</surname><given-names>H</given-names></name><name name-style="western"><surname>Skassa-Brociek</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Specific immunotherapy with a standardized <italic toggle="yes">Dermatophagoides pteronyssinus</italic> extract. II. Prediction of efficacy of immunotherapy</article-title>. <source>J Allergy Clin Immunol.</source> (<year>1988</year>) <volume>82</volume>:<fpage>971</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/0091-6749(88)90133-9</pub-id><pub-id pub-id-type="pmid">3204255</pub-id></mixed-citation></ref><ref id="B161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Des Roches</surname><given-names>A</given-names></name><name name-style="western"><surname>Paradis</surname><given-names>L</given-names></name><name name-style="western"><surname>Menardo</surname><given-names>JL</given-names></name><name name-style="western"><surname>Bouges</surname><given-names>S</given-names></name><name name-style="western"><surname>Daures</surname><given-names>JP</given-names></name><name name-style="western"><surname>Bousquet</surname><given-names>J</given-names></name></person-group>. <article-title>Immunotherapy with a standardized <italic toggle="yes">Dermatophagoides pteronyssinus</italic> extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children</article-title>. <source>J Allergy Clin Immunol.</source> (<year>1997</year>) <volume>99</volume>:<fpage>450</fpage>&#8211;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-6749(97)70069-1</pub-id><pub-id pub-id-type="pmid">9111487</pub-id></mixed-citation></ref><ref id="B162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfaar</surname><given-names>O</given-names></name><name name-style="western"><surname>Bachert</surname><given-names>C</given-names></name><name name-style="western"><surname>Kuna</surname><given-names>P</given-names></name><name name-style="western"><surname>Panzner</surname><given-names>P</given-names></name><name name-style="western"><surname>Dzupinova</surname><given-names>M</given-names></name><name name-style="western"><surname>Klimek</surname><given-names>L</given-names></name><etal/></person-group><article-title>Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2019</year>) <volume>143</volume>:<fpage>970</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2018.11.018</pub-id><pub-id pub-id-type="pmid">30508538</pub-id></mixed-citation></ref><ref id="B163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfaar</surname><given-names>O</given-names></name><name name-style="western"><surname>Agache</surname><given-names>I</given-names></name><name name-style="western"><surname>de Blay</surname><given-names>F</given-names></name><name name-style="western"><surname>Bonini</surname><given-names>S</given-names></name><name name-style="western"><surname>Chaker</surname><given-names>AM</given-names></name><name name-style="western"><surname>Durham</surname><given-names>SR</given-names></name><etal/></person-group>. <article-title>Perspectives in allergen immunotherapy: 2019 and beyond</article-title>. <source>Allergy.</source> (<year>2019</year>) <volume>74</volume>(<issue>Suppl. 108</issue>):<fpage>3</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/all.14077</pub-id><pub-id pub-id-type="pmid">31872476</pub-id></mixed-citation></ref><ref id="B164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>L</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>H</given-names></name><name name-style="western"><surname>Lockey</surname><given-names>R</given-names></name><name name-style="western"><surname>Calabria</surname><given-names>C</given-names></name><name name-style="western"><surname>Chacko</surname><given-names>T</given-names></name><name name-style="western"><surname>Finegold</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Allergen immunotherapy: a practice parameter third update</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2011</year>) <volume>127</volume>(<issue>Suppl. 1</issue>):<fpage>S1</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2010.09.034</pub-id><pub-id pub-id-type="pmid">21122901</pub-id></mixed-citation></ref><ref id="B165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malling</surname><given-names>HJ</given-names></name></person-group>. <article-title>[WHO position paper (summary)&#8211;allergen-immunotherapy: therapeutic vaccines for allergic diseases]</article-title>. <source>Wiener Medizinische Wochenschrift.</source> (<year>1999</year>) <volume>149</volume>:<fpage>410</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="pmid">10584284</pub-id></mixed-citation></ref><ref id="B166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newton</surname><given-names>GK</given-names></name><name name-style="western"><surname>Perrior</surname><given-names>TR</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>K</given-names></name><name name-style="western"><surname>Major</surname><given-names>MR</given-names></name><name name-style="western"><surname>Key</surname><given-names>RE</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>MR</given-names></name><etal/></person-group><article-title>The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen Der p 1: an innovative approach to the treatment of allergic asthma</article-title>. <source>J Med Chem.</source> (<year>2014</year>) <volume>57</volume>:<fpage>9447</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1021/jm501102h</pub-id><pub-id pub-id-type="pmid">25365789</pub-id><pub-id pub-id-type="pmcid">PMC4257840</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>